Predicting Cell Culture Performance in Bioreactors
Through computer simulation modeling and metabolic reaction kinetic analysis, the operation of the bioreactor is optimized, and the problem of inefficient operation in the prior art is solved, and more efficient cell culture performance prediction and reactor control are achieved.
Patent Information
- Application Number
- CN202080024142.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-03-29
- Filing Date
- 2020-03-27
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2040-03-27
AI Technical Summary
Bioreactor operation optimization faces challenges, including when to transition from growth to production, how to control environmental conditions, resulting in expensive and time-consuming in vivo experimental needs.
The computer simulation modeling method is adopted to receive and process the bioreactor process variables, perform metabolic reaction kinetic modeling, generate flux rate constraints, perform flux equilibrium analysis, update process variables, and generate control settings or training sets.
Improves the design and operation efficiency of the bioreactor, reduces experimental costs and time, and provides more accurate prediction of cell culture performance.
Smart Images

Figure SMS_1 
Figure SMS_4 
Figure SMS_10
Abstract
Description
Technical Field
[0001] The present disclosure generally relates to methods for computer simulation modeling of bioreactors and related bioprocesses for the purpose of improving bioprocess design and / or operation. Background Art
[0002] Biotechnology uses living cells to produce valuable biochemical compounds. Different cells can be engineered to produce a variety of target biochemical products for medicinal, agricultural or other uses. Practitioners construct and use bioreactors to grow cell cultures that produce the target product along with other metabolic byproducts. Maximizing the volume and quality of the target product for a given production cost is one of the main goals of bioreactor design.
[0003] Bioreactors can be configured and controlled to operate with different purposes under different modes. The first purpose of this process can be to grow a sufficient amount of cell culture without using more than the necessary amount of substrate nutrients. The type of cell biomass grown in a bioreactor can depend on the application, and some popular biological cultures (such as Chinese hamster ovary (CHO) cells) are used for many different applications. In a kind of operation mode of bioreactor (referred to as batch mode), the growth of biological culture can be carried out without any liquid flowing into or out of the reactor, especially if the bioreactor control system can maintain good growth conditions. Good growth conditions may require appropriate temperature, acidity and the concentration of substrate metabolites. When the growing biomass consumes substrate metabolites, the input flow can help supplement the metabolites required for growth, which forms the fed batch configuration of the bioreactor. Metabolic byproducts produced during the growth period may damage the optimality of growth conditions. Adding input and output flow streams to form a continuous bioreactor configuration can alleviate the negative impact of metabolic byproducts and provide more control in the duration of the cell growth stage. Filters can be added to the output stream to prevent cell biomass from being removed, which forms the perfusion configuration of the bioreactor.
[0004] Once sufficient amounts of biomass have been generated in the bioreactor, the next phase of operation can prioritize the production and collection of target metabolites. Such target products can include therapeutic antibodies or other biologics. Inducing cells to shift metabolic energy from growing biomass to producing target products often involves the introduction of stressors. Stress can include a decrease in the optimal host temperature, which causes cells to expend more energy on non-growth metabolism, thereby increasing target yields.
[0005] Optimizing all phases of bioreactor operation presents significant challenges. The many decisions can include when to transition from growth to production, when to start harvesting, when and in what amounts metabolites are supplied and removed, and how to control the bioreactor environment. Typically, many expensive and time-consuming in vivo experiments are performed to select operating conditions. Alternative approaches for optimizing and controlling bioreactor operations would bring considerable benefits to the industry and the public they serve. Summary of the invention
[0006] The computational method for modeling a bioreactor is used to predict cell culture performance to improve and / or optimize the design and / or operation of the bioreactor. On the one hand, the method includes receiving multiple current values of process variables, which describe the virtual contents of the modeled bioreactor, and these virtual contents include virtual cell biomass in a virtual extracellular solution. The method also includes calculating new values of these process variables during the simulated time period by the processing hardware of the computing system. The method calculates new values at least in part by: modeling one or more effects of at least some of these current values of these process variables on metabolic reaction dynamics, generating multiple constraints for flux rates describing the metabolic flux of the virtual cell biomass; calculating these flux rates of these metabolic fluxes by performing flux balance analysis, which is affected by metabolic targets and multiple constraints generated for these flux rates; calculating the rate of change of at least some of these process variables based on the calculated flux rate at least in part; and updating one or more of these current values of these process variables by integrating one or more of the calculated change rates for virtual time steps within the simulation time period. The method also includes calculating, by the processing hardware, a measure of the computationally modeled bioreactor based on the calculated new values of the process variables, and generating, by the processing hardware and based on the measure of the modeled bioreactor, one or more of the following: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of a bioreactor. For any method described herein, the method may optionally further include culturing mammalian cells in a bioreactor using one or more parameters identified in the modeled bioreactor. For example, mammalian cells may encode therapeutic proteins and may produce the therapeutic proteins when cultured in a bioreactor. Examples of mammalian cells include CHO cells and BHK cells. For simplicity, "bioreactors" may also be referred to as "reactors" herein, and unless otherwise expressly stated, these terms will be understood to be interchangeable herein.
[0007] On the other hand, a non-transitory computer-readable medium stores instructions for computationally modeling a bioreactor, wherein these instructions, when executed by one or more processors, cause the one or more processors to receive multiple current values of process variables, which describe the virtual contents of the modeled bioreactor, and these virtual contents include virtual cell biomass in a virtual extracellular solution. These instructions also cause the one or more processors to calculate new values of these process variables during the simulated time period through the processing hardware of the computing system. The one or more processors calculate new values at least in part by: modeling one or more effects of at least some of these current values of these process variables on metabolic reaction kinetics, generating multiple constraints for flux rates describing the metabolic flux of the virtual cell biomass; calculating these flux rates of these metabolic fluxes by performing a flux balance analysis, which is affected by metabolic targets and multiple constraints generated for these flux rates; calculating the rate of change of at least some of these process variables based at least in part on the calculated flux rate; and updating one or more of these current values of these process variables by integrating one or more of the calculated change rates for virtual time steps within the simulation time period. The instructions also cause the one or more processors to calculate, via the processing hardware, measurements of the modeled bioreactor based on the calculated new values of the process variables, and to generate, via the processing hardware and based on the measurements of the modeled bioreactor, one or more of: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of a bioreactor. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] Figure 1 An exemplary process and corresponding computational model for computationally modeling a bioreactor are presented.
[0009] Figure 2 It is depicted in Figure 1 A diagram of an exemplary effect of temperature variation on a stress variable in an embodiment of a modeling process.
[0010] Figure 3 Demonstrated that it can be implemented Figure 1 An exemplary computer system for a modeling process.
[0011] Figure 4A and 4B A panel of an exemplary user interface for receiving user input is shown.
[0012] Figure 5 An exemplary user interface for displaying output to a user is shown.
[0013] Figure 6 An exemplary bioreactor control system is presented.
[0014] Figure 7 is a flow chart depicting an exemplary method for computationally modeling a bioreactor.
[0015] Figure 8 A comparison between the bioreactor model and experimental observations is presented.
[0016] Fig. 9A and 9B The relationship between the metabolic model of a heterogeneous bioreactor modeled with homogeneous parts and the velocity field that can be calculated using computational fluid dynamics (CFD) is shown. DETAILED DESCRIPTION
[0017] Most of the description herein focuses on metabolic (biological and biochemical) models of bioreactors that are configured, for example, to produce a certain bioproduct. Although the description primarily views the bioreactor as a homogenous mixture of extracellular solution and cellular biomass, adjustments to the metabolic model can be readily made to account for spatial heterogeneity in the bioreactor. To this end, the metabolic model can be integrated with computational models of transport physics in computer simulations. Thus, certain portions of the description describe model integration, demonstrating the general applicability of the metabolic model to bioreactors that do not require adequate mixing.
[0018] Figure 1An exemplary process 100 is shown for computationally modeling a bioreactor with a corresponding computational model 104 represented by a virtual space 110 in a series of time steps (including the depicted time step 102). It should be understood that during the modeling process 100, the time step 102 can be repeated any suitable number of times. The virtual contents of the modeled bioreactor 120 can include a virtual extracellular solution 124 and a virtual cell biomass 130 disposed within the virtual extracellular solution 124. For convenience, the modeled bioreactor 120 can be referred to herein as a "bioreactor", the virtual extracellular solution 124 can be referred to herein as an "extracellular solution" (or simply "solution"), and the virtual cell biomass 130 can be referred to herein as "cell biomass" (or simply "biomass"). A set of fluxes 132a-132i can at least partially represent the state of the biomass 130. The virtual input flow 140 and the virtual output flow 142 can replenish and consume the virtual contents of the modeled bioreactor 120, respectively. The virtual filter 144 can selectively promote, allow, restrict or prevent some contents from flowing out of the modeled bioreactor 120. For example, to model a bioreactor in a perfusion mode of operation, the filter 144 can allow the flow of the extracellular solution 124 while restricting or preventing the flow of the cell biomass 130. Conversely, excluding or zeroing the virtual input stream 140 and the virtual output stream 142 is to model a bioreactor in a batch mode of operation. In general, changing the flow and / or composition of the virtual input stream 140 and the virtual output stream 142 can allow the batch, fed-batch, continuous and / or perfusion configuration or mode of operation of the bioreactor 120 to be modeled.
[0019] In some embodiments, the modeling process 100 can be configured to model the spatial heterogeneity of the bioreactor. Spatial heterogeneity can refer to, for example, the composition of the extracellular solution, the concentration or composition of the cell biomass, or the spatial differences of other process parameters (e.g., temperature) at different locations in the bioreactor. In a well-mixed bioreactor, such differences may be smaller, and a homogeneous model can simulate a well-mixed bioreactor with sufficient accuracy. On the other hand, when modeling a poorly mixed bioreactor, computationally considering spatial heterogeneity can greatly improve the accuracy of the model. For this reason, the metabolic model described herein can be coupled with a physical model of mass and heat transfer in the reactor. In some embodiments, a computational fluid dynamics (CFD) model can cooperate with the metabolic model discussed herein. Typically, in view of the trade-off between accuracy and computational complexity, heterogeneity can be modeled.
[0020] In order to model spatial heterogeneity using the modeling process 100, the modeled / virtual bioreactor 120 can model a portion of a heterogeneous bioreactor. Therefore, in the context of a spatially heterogeneous bioreactor model, the bioreactor 120 can be considered as a portion of a heterogeneous bioreactor. That is, depending on, for example, the degree of heterogeneity and the coupled physical model, the simulated heterogeneous bioreactor can be divided into several parts in any of a variety of suitable ways. In some embodiments, at least 2, 5, 10, 20 or other suitable numbers of parts (including the range between any two of the listed values) of different sizes can represent different regions of the bioreactor (e.g., inlet and outlet, central part, etc.). In some embodiments, the bioreactor volume can be divided into at least 100, 1000, 10000, 100000, 100000 or any other suitable number of parts (including the range between any two of the listed values), which are represented by finite volume elements, which can also, for example, serve as finite volume elements of a CFD model.
[0021] It can be assumed that the modeled portion represented by the bioreactor 120 is substantially homogeneous. Therefore, the extracellular solution 124 can be used as a model of a portion of the extracellular solution corresponding to the modeled portion of the heterogeneous reactor, and the biomass 130 can be used as a model of the corresponding portion of the biomass distributed throughout the heterogeneous bioreactor. The input stream 140 can be used as a model of mass transfer (i.e., flow of extracellular solution and biomass) from one or more adjacent portions of the heterogeneous bioreactor into the portion of the heterogeneous bioreactor (simulated by the bioreactor 120). Similarly, the output stream 142 can be used as a model of mass transfer (i.e., flow of extracellular solution and biomass) from the portion of the heterogeneous bioreactor (represented by the bioreactor 120) into the adjacent portion of the heterogeneous bioreactor. In this way, a group of homogeneous bioreactor models (each representing a portion of the heterogeneous bioreactor) can be connected to model the heterogeneous bioreactor. The input and output streams that supplement and consume the heterogeneous bioreactor can be added to the input stream 140 and the output stream 142 of a portion of the heterogeneous bioreactor that has an input from or an output to the outside of the heterogeneous bioreactor. In this case, at least a portion of the input stream 140 and the output stream 142 can be considered to take into account the input and output boundary conditions of the heterogeneous bioreactor model assembled from the homogeneous bioreactor model.
[0022] The computational (e.g., CFD) model can be configured to calculate the input and output flows (e.g., flows 140, 142) of each portion (e.g., bioreactor 120) of the heterogeneous bioreactor model. In some embodiments, each portion of the heterogeneous bioreactor modeled by process 100 can correspond to a finite volume element of the CFD model as discussed above. However, in general, the spatial discretization for the CFD model does not need to be the same as the spatial discretization of the reactor portion for applying the simulation process 100. For example, the CFD model can calculate the velocity field within the modeled heterogeneous bioreactor at one spatial resolution. The velocity field can be combined with the composition of the bioreactor calculated by the metabolic model at different spatial resolutions to update the input flow 140 and the output flow 142 for each of the bioreactor portions represented by the metabolic model.
[0023] The calculation of velocity field can depend on the physical configuration (e.g., mixing mechanism) of the bioreactor. In some bioreactors, natural convection can be the main mixing mechanism. That is, the temperature gradient caused by metabolic processes or reactor temperature control can drive convection. In other embodiments, the injected fluid (e.g., liquid substrate or gas) can drive convection. Additionally or alternatively, an impeller or other suitable mixing mechanism can drive the mixing process. Calculation or empirical models can be used to calculate the velocity field under a suitable time scale. For example, after calculation, it can be assumed that the velocity field is substantially constant until the physical properties of the bioreactor contents (e.g., viscosity changes caused by biomass growth) or the mode of driving the mixing process (e.g., changes in input or output flow rates imposed by the control of the bioreactor) change substantially.
[0024] As with spatial resolution, the temporal resolution of the metabolic model and the physical model need not be the same (at least in light of the above discussion). That is, the time step 102 of the modeling process 100 describes the metabolic process model. Reference is made herein as needed to various aspects of the integration of the modeling process 100, which is applied to portions of a heterogeneous bioreactor, where mixing processes (e.g., by CFD) or other physical processes within the heterogeneous reactor are modeled.
[0025] The modeling process 100 and computational model 104 implemented in software (running on the hardware of a computing system) can simulate the operation of a virtual bioreactor 120 over a simulation period consisting of a series of time steps 102. The modeling process 100 includes: receiving (from a user or a previous time step 102) current values 150a of process variables at the beginning of the time step 102; and generating updated values 150b of at least some of those process variables through a series of computational steps at the end of the time step 102. In the context that the precise timing relative to any given time step 102 is not an issue, the current values 150a and updated values 150b can be simply collectively referred to herein as "values" of the process variables. The process variables can be a set of variables that describe the computational model 104 of the bioreactor. In some embodiments, the process variables can reflect the values of the control variables 152, process conditions, experimental conditions, culture medium composition, bioreactor parameters, model constants, and / or various other terms that describe the parameters of the computational model 104. Process variables may include variables describing or indicating various physical, chemical, and biochemical properties of the extracellular solution 124, such as volume, temperature, acidity or pH, osmotic pressure, mass, density, and chemical and biochemical composition of the solution. In addition, process variables may indicate the amount or concentration of cell biomass 130 disposed in the extracellular solution 124 within the modeled bioreactor 120. Additionally or alternatively, process variables 150 may indicate the concentration or absolute amount of various inorganic or organic metabolites disposed in the extracellular solution 124 or within the biomass 130. Dissolved metabolites (whose extracellular or intracellular concentrations are indicated by process variables 150) may include gases, salts, ions, metals, minerals, sugars, amino acids, fatty acids, and / or other organic acids and / or their conjugate bases. More specifically, dissolved metabolites may include oxygen, carbon dioxide, ammonia, glucose, sucrose, lactose, lactate, glutamine, glutamate, alanine, asparagine, aspartate, and / or various other chemical or biochemical substances. The process variable may also indicate the concentration of one or more target metabolites (or simply, target products), which may include antibodies, peptides, therapeutic proteins, or other biologics. The process variable may also indicate the concentration of one or more of the various metabolic byproducts (or simply, byproducts), which together with the target products may be produced by the virtual cell biomass 120. Target products and byproducts may be collectively referred to as metabolites (or simply, products).
[0026] To determine a value 150b of a process variable to be updated from a current value 150a of the process variable, the modeling process 100 may calculate the speed or rate of at least some of the fluxes 132a-132i associated with the cell biomass 130. The fluxes 132a-132i may correspond to the growth 132a of the cell biomass 130, the uptake 132b, 132c of substrate metabolites, the removal or secretion 132d, 132e of metabolic target products and byproducts, and / or fluxes representing various intracellular metabolic pathway fluxes 132f-132i. The intracellular metabolic pathway fluxes 132f-132i may represent metabolic conversion of several metabolites into several other metabolites, such as Figure 1 In the topology indicated by the flux representation. For example, flux 132f can represent a reaction or metabolic pathway in which two metabolites are combined to produce another metabolite, flux 132g can represent a reaction or metabolic pathway in which one metabolite produces another two metabolites, flux 132h can represent a reaction or metabolic pathway in which two metabolites are combined to produce another two metabolites, and flux 132i can represent a reaction or metabolic pathway in which two metabolites are combined to produce three metabolites. In some embodiments, growth flux 132a can be modeled as the output of another flux (which additionally represents an intracellular metabolic process). Collectively, fluxes 132a-132i can represent a metabolic network for modeling a given type of cell that produces cell biomass 130. The metabolic network for the modeled bacterial cell (such as Escherichia coli (E.coli)) can be different from the metabolic network for the modeled mammalian germ cell (such as CHO cell). Figure 1 The fluxes 132a-132i in are for general illustration, and a metabolic network may contain fluxes having from zero to more than twelve inputs and / or outputs. In addition, a metabolic network may contain 5, 20, 100, 500, 2500 or any other suitable number of metabolic pathways.
[0027] The intracellular metabolites arranged in the cell biomass 130 modeled by the flux 132a-132i of the metabolic network can include some or all of the metabolites modeled in the extracellular solution: oxygen, carbon dioxide, ammonia, other gases, salts, ions, metals, minerals, glucose, sucrose, lactose, lactate, glutamine, glutamate, glycine, alanine, asparagine, aspartate and / or various other chemicals or biochemicals. The intracellular metabolites participating in the flux 132a-132i can also include various enzymes, proteins, amino acids and / or ADP (adenosine diphosphate) and ATP (adenosine triphosphate) molecules involved in energy transfer. Variables indicating the concentration of intracellular metabolites can be included in the process variables.
[0028] Each metabolic pathway flux can be quantified by flux rate, and this flux rate characterizes the conversion rate of the metabolite related to flux. Flux rate can also be referred to as flux speed in this article. Some flux rates can represent, be equivalent to, indicate the rate of change of some process variables about time or otherwise be related to this rate of change. For example, the rate of growth flux 132a can represent the rate of change of following process variable, and this process variable indicates the concentration or the total amount of cell biomass 130 arranged in extracellular solution 124. At least under some modeled bioreactor operating conditions, the rate of metabolite uptake flux 132b or 132c can represent the rate of change of following process variable, and this process variable indicates the amount or concentration of corresponding metabolite in extracellular solution 124. For example, the rate of oxygen uptake can represent the rate of change of following process variable, and this process variable indicates extracellular oxygen concentration, and the rate of glucose uptake can represent the rate of change of following process variable, and this process variable indicates glucose concentration. The rate of flux corresponding to the production of a target product or byproduct by the cellular biomass 130 may represent the rate of change of a process variable related to the amount or concentration of the corresponding target product or byproduct in the extracellular solution 124 .
[0029] As described above, in addition to the extracellular solution 124 and the cell biomass 130, the computational model 104 may also include a description of one or more virtual input streams 140 and / or one or more virtual output streams 142. Herein, for simplicity, the one or more input streams 140 may be referred to as the singular "virtual input stream" or "input stream", and for simplicity, the one or more output streams 140 may be referred to as the singular "virtual output stream" or "output stream". The descriptions of the streams 140, 142 may include variables that indicate the composition and / or flow rates associated with the input stream 140 and the output stream 142. In some embodiments, the absolute value of the sum of the volumetric flow rates of the liquid input streams 140 and the absolute value of the sum of the volumetric flow rates of the output streams 142 are equal, which makes the volume of the extracellular solution constant. Embodiments in which the flow rate of the input stream 140 and the flow rate of the output stream 142 are unbalanced result in a change in the volume of the extracellular solution 124. The virtual input stream 140 and the virtual output stream 142 may affect the rate of change of process variables, including a process variable indicative of the composition of the extracellular solution 124 , such as by replenishing substrate metabolites and / or depleting the virtual contents of the modeled bioreactor 120 .
[0030] Returning to the modeling process 100, the current value 150a of the process variable can be used as the input of the kinetic model 160. The kinetic model 160 can calculate several constraints 164 for flux rate (i.e., the speed of at least some of the flux 132a-132i related to the biomass 130). For example, the constraint 164 can specify the upper limit of the flux rate representing the substrate metabolite uptake. Therefore, the constraint 164 can constrain the rate of change of the following process variables, which indicate the amount or concentration of the substrate metabolites related to the constrained flux. For example, these constraints can represent the maximum uptake rate of oxygen, glucose, asparagine and / or glutamine and / or glycine, and accordingly, in the absence of the influence of the input stream 140 and the output stream 142, the maximum rate of change of the following process variables, which indicate the amount or concentration of oxygen, glucose, asparagine, glutamine and / or glycine in the extracellular solution 124.
[0031] The kinetic model 160 can calculate the effect of the current value 150a of the process variable on the metabolic reaction kinetics, which in turn affects the constraints on the flux rate. For example, as calculated by the kinetic model 160, the maximum uptake rate can depend on other process variables that indicate or describe the physical or chemical properties of the extracellular solution 124. As a more specific example, process variables indicating the temperature, acidity or pH, and / or osmolarity of the extracellular solution may affect the maximum uptake rate.
[0032] The kinetic model 160 can calculate the effect of the current value 150a of the following process variables on the maximum metabolite uptake rate by weighting the optimal maximum uptake rate or multiplying the optimal maximum uptake rate with process condition factors (which cause deviations from optimal conditions), which process variables indicate temperature, acidity and / or osmotic pressure. Under ideal process conditions, the optimal maximum uptake rate can correspond to an upper limit for the uptake rate. The process condition factors can then serve as correction factors that indicate the decrease in uptake rate due to non-ideal conditions. The process condition factors can be defined in various functional forms. For example, for a given metabolite uptake, the process condition factors can have a uniform value for the optimal process conditions, and the uniformity decreases as the deviation from the optimal process conditions increases. The process condition factors can take different or similar forms for different metabolite uptake rates, and the optimal conditions can be different or similar for different metabolite uptakes.
[0033] In some embodiments, the kinetic model 160 calculates the effect of current values 150a on metabolic reaction kinetics, which are indicative of the concentration of one or more metabolic byproducts. For example, the concentration of ammonia and lactate may reduce the maximum uptake rate of glucose, glutamine, asparagine, and other substrate metabolites.
[0034] In some embodiments, the kinetic model 160 models the effect of the current value 150a of the process variable on the rate constraints of the intracellular metabolic flux and the corresponding energy consumption rate responsible for cell maintenance. The cell maintenance flux can be used as a model of a metabolic pathway that consumes some of the energy available to the cell biomass 130 in the form of ATP without growing the cell biomass 132. In some embodiments, the cell maintenance flux can be tightly coupled to the flux that produces the target product. In other words, calculating the constraint on the flux rate produced for the target product can include calculating the lower limit of the energy consumption rate for cell maintenance.
[0035] In order to calculate the lower limit of the energy consumption rate maintained for the cell, the kinetic model 160 can consider the influence of the relevant current value 150a of the process variable. In some embodiments, the "stress" variable can be defined to quantify the influence of the lower limit of the energy consumption rate maintained for the cell by the process variable. Conversely, stress can be a function of the temperature difference experienced or felt by the extracellular solution temperature over time and the cell biomass 130. In some embodiments, stress is assessed as the cumulative impact of the temperature difference integrated over time. Additionally or alternatively, in some embodiments, different stress variables help to calculate the minimum energy consumption rate maintained for the cell, and / or stress variables cause the state or change in terms of the high cell density of temperature, osmotic pressure, byproduct concentration and / or biomass 130.
[0036] The calculation of the effect of the current process variable 150a on the flux rate constraint 164 by the kinetic model 160 can be based on experimental data. The mathematical formula used for the calculation can be derived from the theoretical model, can be empirically derived, and / or can combine empirical factors with theoretical derivation. In any case, the formula for calculating the effect of the current process variable 150a may include the following coefficients or model parameters, which can be obtained by a calibration procedure (e.g., by fitting calibration data). In some embodiments, the calibration data includes experimental data. Additionally or alternatively, the data generated by calculation can be used for at least some of the calibration. Fitting, regression and / or optimization algorithms can help calculate the kinetic model parameters from the calibration data.
[0037] In some embodiments, the kinetic model updates at least some of the process variables based on the control variables 152 before calculating the effect of the process variables on the flux rate constraints 164. The control variables may include temperature settings, acidity settings, or any other suitable variables that may represent virtual control settings for the bioreactor 130. The modeling process 100 may receive the control variables 152 prior to starting a simulation (where the relevant time is within the simulated time period) or may receive the control variables 152 at any time during the simulation time period.
[0038] As discussed above, the constraints 164 calculated by the kinetic model 160 can define upper or lower limits on the rates of some of the fluxes 132a-132i, which are used as models of the metabolic pathways of the virtual cell biomass 130. The modeling process 100 can then use the constraints 164 to perform a flux balance analysis 170 that simultaneously calculates flux rates 174 for all modeled fluxes within the metabolic network of the cell biomass 130. The flux balance analysis 170 can determine flux rates that ensure that the intracellular metabolite concentrations in the modeled biomass 130 are substantially in steady state. For example, if one of the fluxes consumes certain intracellular metabolites while producing other metabolites, the other fluxes can balance the first flux by consuming or removing all metabolites produced by the first flux and producing all metabolites consumed by the first flux or taking up all metabolites consumed by the first flux from the extracellular solution 124. Metabolites taken up by flux into the cell biomass 130 may be removed from the extracellular solution 124, and metabolites removed by flux from the cell biomass 130 may be deposited into the extracellular solution 124. Thus, while a flux balance analysis may maintain the rate of change of the concentration or amount of an intracellular metabolite at substantially zero, it may have an effect on the rate of change of extracellular metabolites, which may include substrate metabolites, target products, and byproducts, and related process variables.
[0039] In addition or alternatively to help calculate changes in extracellular metabolite concentrations, the flux balance analysis 170 can determine the growth rate of the cell biomass 130. In some embodiments, the determined growth rate can be negative, as a model of cell death or cell biomass 130 loss. The death or loss of the modeled cell biomass 130 can occur in the following circumstances: the constraints for the flux rate include a lower limit on the energy consumption rate for cell maintenance, and in view of other flux rate constraints, the metabolic flux cannot produce energy at the required rate. In this case, the modeling process 100 can ignore the minimum maintenance energy constraint for the flux balance analysis 170, and the death rate can be calculated based on the deficiency in the maintenance energy production rate.
[0040] In addition to the constraints 164 calculated by the kinetic model 160, the flux balance analysis 170 can also use the metabolic target 172 (or simply, the metabolic target) limited by the modeling process 100 to represent the biological target of the virtual biomass 130. In the absence of the metabolic target function 172, the flux balance analysis 170 may not be able to obtain a unique solution, but may obtain a solution space, which has many or infinite sets of possible flux rates, and these flux rates keep the intracellular metabolites in a steady state. Therefore, the effect of the metabolic target function can be to limit the flux balance analysis 170 to obtain a unique solution. In other embodiments, the solution of the flux balance analysis 170 may not be unique, even when the metabolic target function 172 is included.
[0041] Various metabolic objective functions 172 can be used in different embodiments. For example, the metabolic objective function 172 can result in the following flux balance analysis 170 solution, which obtains the maximum value of the growth rate of the cell biomass 130. Alternatively, the metabolic objective function 172 can result in the following flux balance analysis 170 solution, which obtains the minimum value of the linear combination of metabolite uptake rates. The linear combination can be the sum or weighted sum of some or all of the uptake flux rates. In some embodiments, the metabolic objective function combines multiple requirements, restrictions or constraints. For example, the metabolic objective function 172 can combine the growth rate with the maximum value while minimizing the linear combination of the uptake flux rate. In another embodiment, the metabolic target 172 minimizes the linear combination of the uptake flux rate while maximizing the flux related to the cell maintenance energy.
[0042] Some or all of the flux rates 174 calculated by the flux balance analysis 170 may correspond to the rate of change of some of the process variables without the effects from the input streams 140 and the output streams 142. The rates 174 may be input to a rate integration module 180, which may use the rates to calculate updated values 150b for the process variables. The updated values 150b for the process variables may then become the current values 150a for the process variables for the next time step.
[0043] The rate integration module 180 can use the flux rate 174 provided by the flux balance analysis module 170 to calculate the time rate of change of the process variables. In some embodiments, the time rate of change of some of the process variables directly corresponds to some of the flux rate 174. In other embodiments, input and output flow variables 182 describing the input stream 140 and the output stream 142 help calculate the rate of change of the process variables. The input and output flow variables 182 can contain information about the flow rate and composition of the input stream 140 and the output stream 142. When the bioreactor 120 is modeled in a batch operation mode, the influence of the input stream 140 and the output stream 142 can be ignored. When the bioreactor 120 is modeled in a fed-batch operation mode, the flow variables 182 corresponding to the input stream 140 can have an influence on the calculation of the updated value 150b of the process variable. When the bioreactor 120 is modeled in a continuous or perfusion mode of operation, the flow variables 182 corresponding to both the input stream 140 and the output stream 142 can each contribute to the calculation of the updated value 150b of the process variable. In some embodiments, when, for example, the contents of the modeled bioreactor 120 are virtually harvested without replenishment, only the flow variable 182 corresponding to the output stream 142 contributes to the rate of change of the process variable 150.
[0044] The flow variables 182 defining the input stream 140 and the output stream 142 (both of which have an effect on the calculation of the updated set of process variables 150b) may include the total volumetric flow rates of the streams 140, 142 (which may be equal or unequal), and flow variables defining the composition of the input stream 140 and the output stream 142. The composition of the input stream 140 may be defined directly by the input flow variables (i.e., independent of the calculations performed in the modeling process 100), while the calculation of the composition of the output stream 142 may depend on the current values 150a of the process variables that describe the composition of the extracellular solution 124. Additionally or alternatively, the flow variables 182 that have an effect on the calculation of the composition of the output stream 142 may define the selectivity of the output filter 144. For example, the glucose concentration of the input stream 140 can be defined directly as an input flow variable, while the glucose concentration of the output stream 142 can be calculated from the output flow variable indicating the glucose selectivity of the output filter 144 and a process variable indicating the glucose concentration in the extracellular solution 124. Similarly, for other metabolites or cellular biomass 130, the calculation of the concentration in the output stream 142 can depend on process variables indicating the corresponding concentration in the extracellular solution 124 and the output flow variables indicating the corresponding value of the output filter 144 selectivity.
[0045] When modeling bioreactor heterogeneity, input flow 140 and output flow 142 can represent flows connecting different bioreactor sections (each modeled as a homogeneous bioreactor (e.g., bioreactor 120)), as discussed herein. Thus, given the velocity field obtained from a physical model (e.g., a CFD model), input and output flow variables 182 can be calculated.
[0046] The rate integration module 180 can use the flux rate 174, the input / output flow variable 182 that combines the input flow variable and the output flow variable, and the current value 150a of the process variable to construct a differential or difference equation. Subsequently, the rate integration module 180 can use a numerical differential or difference equation solver to calculate the updated value 150b of the process variable. The time step 102 for integrating the rate can be equal to a few seconds, a few minutes, a few hours, a few days, or any other suitable time period, depending on the implementation. Once the updated value 150b of the process variable is calculated, the modeling process 100 can replace one or more of the current values 150a of the process variable with the updated value 150b. The replaced current value 150a can be discarded or saved in a computer memory for further calculation. The modeling process is repeated in the next time step (e.g., the same duration as the time step 102) using a new set of current values 150a, and repeated until the simulated time period expires.
[0047] In a heterogeneous bioreactor, the current value 150a and updated value 150b of the process variable can be considered as samples or representative values of the spatial distribution of the process variable (for each bioreactor section). Therefore, the differential or difference equation constructed by the integration module 180 can be a partial differential or difference equation with a partial time derivative, as described below. The integration module 180 can construct spatial partial derivatives (or differences) based on the process variable values in adjacent regions. The integration module 180 can combine the spatial partial derivatives of the process variable values with a velocity field (e.g., calculated by a CFD model) to calculate an updated value 150b of the process variable. In an example embodiment, the dot product between the gradient vector of the process variable and the local velocity can represent the difference between the input flow 140 and the output flow 142 for a finite volume region that represents a portion of a heterogeneous bioreactor.
[0048] In some embodiments, some of the process variables are updated based on the received values of the control variables 152. In some embodiments, the kinetic model 160 uses the control variables to update the values of the process variables, and then uses the process variables to calculate the constraints 164 for the flux rate. Other parts of the modeling process may also update the process variables based on the control variables 152. The control variables may include temperature settings at different times of the simulated time period, the time to change the filter 144, the time to change the rate and / or composition of the input stream 140 and the output stream 144, or any other suitable variable that can represent a virtual control setting for the bioreactor 130. In some embodiments, the rate integration module 180 can construct and solve differential or difference equations that represent the gradual response of the process variables to the corresponding control variables. For example, when the temperature control variable changes from one time step 102 to the next, the process variable for the temperature of the extracellular solution can be adjusted by the rate integration module 180 over multiple time steps. In other embodiments, the process variables immediately receive the value of the control variable, thereby modeling a faster response than the virtual time step 102.
[0049] The foregoing discussion illustrates and provides details of exemplary embodiments of the kinetic model 160. As discussed above, by modeling one or more effects of at least some of the current values 150a of the process variables on the metabolic reaction kinetics, the kinetic model 160 generates multiple constraints 164 for flux rate. For example, the modeled effects can include the influence of temperature, acidity and / or osmotic pressure on the upper limit of the metabolite uptake rate. The model can define the upper limit of the flux rate associated with a given metabolite uptake for some ideal conditions, which can include ideal temperature, ideal acidity and / or ideal osmotic pressure. The kinetic model 160 can calculate the influence of non-ideal conditions by multiplying the upper limit for ideal conditions with a correction factor. The following correction factor can be defined as a function of one or more variables (such as temperature, acidity and / or osmotic pressure), and the correction factor indicates that the uptake rate caused by non-ideal conditions is reduced. In some embodiments, the correction factor or includes the influence of the concentration of metabolic byproducts (such as lactate or ammonia).
[0050] For example, under ideal conditions, the upper limit on the uptake rate for glucose can be modeled by the following equation:
[0051]
[0052] When conditions for glucose uptake are ideal and the glucose concentration in the extracellular solution is large enough that any further increase does not significantly increase the glucose uptake rate, v GLC near In Equation 1, [GLC] is the glucose concentration, and is a kinetic model parameter that describes the dependence of the glucose uptake flux rate on glucose concentration. When conditions are not ideal for glucose uptake, a correction factor (e.g., C GLC (T, pH, π, [LAC], [NH3]) < 1) can be multiplied by the glucose uptake rate, where the correction factor can depend on a variety of factors, including temperature T, acidity pH, osmolarity π, lactate concentration [LAC] and / or ammonia concentration [NH3]:
[0053]
[0054] The correction factor may depend on 1, 2, 3, 4, 5, or any other suitable number of current values of the process variables. GLC (T, pH) can be expressed as a correction depending on temperature and acidity, while the correction factor C GLC (T, π, [NH3]) may represent a correction that depends on temperature, osmolarity, and ammonia concentration. A correction factor that depends on multiple variables may combine multiple correction factors that depend on one or more variables. For example, C GLC (T, pH, π, [LAC]) It is possible to combine four individually defined correction factors as follows: For example, the correction factor for temperature Correction Factor for Acidity Correction Factor for Osmolarity and correction factor for lactate concentration The combination of constitutive factors can take various mathematical expressions that can appropriately represent the dependence of reaction kinetics on environmental factors in a mechanistic model. For example, in some embodiments, correction factors that depend on multiple variables combine constitutive correction factors by multiplication, as illustrated by the following equation:
[0055]
[0056] In another embodiment, the correction factor depending on multiple variables combines the constituent correction factors in another way:
[0057]
[0058] in is the kinetic model 160 parameter for calibration. In the above equation, if Then both the correction factor for temperature and the correction factor for acidity would have to be zero in order for the total correction factor to also be zero.
[0059] The correction factor is described above as a correction factor for glucose uptake for illustrative purposes only. The correction factor for glutamine uptake, asparagine uptake, or another metabolite uptake can have a similar form. In general, for any metabolite M, the correction factor can depend on multiple process variables, including, for example, temperature, acidity, osmotic pressure, lactate concentration, ammonia concentration, and / or any other metabolite (generally designated as M2) that can affect the maximum uptake flux rate for M. The resulting correction factor C M (T, pH, π, [LAC], [NH2], [M2]) The following individually defined correction factors can be combined: Correction factor for temperature Correction Factor for Acidity Correction Factor for Osmolarity Correction factor for lactate concentration Correction factor for ammonia concentration and the correction factor for M2 concentration
[0060] Correction factors for individual process variables can take various mathematical forms that represent the mechanistic dependence of the flux rate constraint on the environment. These correction factors can be derived from first principles or empirically observed. Correction factors for temperature can take the following forms:
[0061]
[0062] The temperature is between the minimum and maximum values, so T min <T<T max , d temp is a positive coefficient of dependence, and The correction factor is normalized to have a maximum unity value. The correction factor for acidity can take the following form:
[0063]
[0064] The acidity represented by pH is between the minimum and maximum values, so pH min <pH<pH max ,and The correction factor is normalized to have a maximum unity value. The correction factor for osmolarity can take the following functional form:
[0065]
[0066] Where π>0 is the permeability, π S and π 0.5 is the coefficient that determines the dependence on osmotic pressure, and The correction factor is normalized to have a maximum unity value. The correction factor for the effect of metabolite concentration can take the form of a saturation equation:
[0067]
[0068] where [M2] is the concentration of the metabolite that limits the uptake flux, and is the coefficient that determines the dependence of the uptake flux rate limit of M on [M2].
[0069] In an exemplary embodiment, the maximum uptake rates for glucose, glutamine, asparagine, and oxygen, respectively, can be calculated in the following manner:
[0070]
[0071] where the correction factor due to non-ideal temperature and acidity is C GLC (T, pH), C GLN (T, pH), C ASN (T, pH), and And the concentrations of glucose [GLC], glutamine [GLN], asparagine [ASN], lactate [LAC], glutamate [GLU], ammonia [NH3], aspartate [ASP] have an effect on some uptake rates, and the kinetic model 160 parameters for calculating the limits of the above-mentioned uptake flux rates are summarized in Table 1 below according to the relevant kinetic mechanisms. In some embodiments, the input to the equation is the extracellular concentration of the metabolite, and in some embodiments, the input to the equation is the intracellular concentration. In other embodiments, a combination of the extracellular and intracellular concentrations of the metabolite can be an input for calculating the constraints 164 for the flux rate. In some embodiments, additional kinetic model 160 parameters quantify the dependence of the uptake flux rate on temperature, acidity, and a combined correction factor.
[0072] Table 1. Kinetic model parameters
[0073]
[0074] For calculating the constraint of metabolite uptake flux rate, additionally or alternatively, the kinetic model 160 can calculate the constraint of one or more flux rates for metabolic processes, which determine the energy consumption for the generation of cell maintenance and / or target product. The constraint for metabolite uptake rate can be the upper limit for uptake rate, and the constraint for maintaining energy can be the lower limit of the relevant flux rate. Maintaining energy represents the modeled metabolic demand of virtual cell biomass 130, which can reflect the energy used by real cells to survive in a real environment. Energy can be represented by the intracellular concentration or amount of ATP. When the energy or ATP produced by cell biomass 130 exceeds required for maintenance, cell biomass can grow with a positive growth rate. On the other hand, when cell biomass 130 cannot produce the amount of ATP or energy required for maintenance, cell biomass 130 may begin to reduce or almost die. Modeling process 100 can illustrate the reduction of cell biomass 130 caused by cell death or loss by assigning a negative growth rate to the equation for growth.
[0075] The lower bound of the cell maintenance energy required to prevent cell biomass from decreasing can depend on various environmental factors represented by one or more process variables. The kinetic model 160 can calculate a stress variable or factor S to represent at least some of the environmental factors that affect the maintenance energy requirement. The modeling process 100 can then calculate the minimum maintenance energy as the minimum rate of ATP consumption, as follows
[0076]
[0077] where v ATP,min represents the maintenance energy requirement when there is no stress (or S = 0), and k S,mnt is a coefficient that adjusts the effect of the stress variable. Although the above equation represents the linear dependence of the maintenance energy requirement on S, the kinetic model 160 can use other functional forms, including polynomials, square roots or other fractional powers, logarithms, exponentials or combinations of the foregoing forms, or any other suitable relationship. The stress variable itself can be calculated based on temperature, acidity and / or any other suitable process variables and their changes over time. The stress variable may include a dependence on the concentration of a metabolite (such as a metabolic byproduct). However, in some embodiments, the kinetic model 160 may separately include the effects of some metabolite concentrations in calculating the minimum maintenance energy, as shown in the following exemplary equation:
[0078]
[0079] where k mnt When there is a significant lactate concentration [LAC] in the extracellular solution (or in some embodiments, in the intracellular solution) >> Kmnt,LAC and ammonia concentration The maximum additional energy or ATP consumption rate that is close to the time Kinetic model parameters for determining the effects of lactate and ammonia, respectively, on the minimum maintenance energy. Although the above equations show a single additional term that explains the effects of both metabolites, separate additional terms or any other suitable functional dependencies can account for metabolite concentrations or other environmental factors that affect the minimum maintenance energy or minimum ATP consumption rate for cell maintenance.
[0080] After calculating the lower bound of the maintenance energy, the kinetic model 160 can additionally calculate the minimum rate for producing the target product. The target product can be an antibody or another suitable biological product. The kinetic model 160 can calculate the lower constraints for the production of the target product by using the proportional relationship between the minimum maintenance energy and the product production, and applying correction factors that account for non-ideal conditions for product production. For example, the kinetic model 160 can calculate the minimum rate for product production, where the target product is an antibody, by the following equation:
[0081]
[0082] Among them C ANTI (T, pH) is a correction factor that accounts for reduced antibody production due to non-ideal temperature and acidity; [LAC] is lactate concentration; K i,ANTI / LAC is a kinetic model parameter reflecting the inhibitory effect of lactate on product formation; and β is a proportionality constant related to the rate of ATP consumption for maintenance and the rate of antibody production. Correction factor C ANTI (T, pH) can have a similar functional dependence on temperature and acidity as the correction factor for metabolic uptake rate. For example, other correction factors can be included in the calculation of the lower limit of antibody or other target product production, which account for the additional inhibitory effects of metabolites.
[0083] Kinetic model parameters (parameters used in equations 1-15 and listed in Table 1) can be obtained using a calibration procedure (or simply, calibration). Experiments performed for calibration purposes can provide experimental calibration data. The experiment used for calibration can be a perfusion experiment, a small-scale batch experiment or a chemostat experiment, and / or any other suitable experiment. Additionally or alternatively, the calibration data can be modified from published literature, theoretical calculations, and / or any suitable combination of sources. The calibration procedure can apply various regression, fitting, or optimization techniques and / or algorithms (including, for example, Levenberg-Marquardt, differential evolution, and / or genetic algorithms) to the calibration data to find the kinetic model parameters. The calibration procedure can combine global and local optimization algorithms, and can use one or more of various suitable cost functions or objective functions. The calibration procedure can calculate the kinetic model parameters individually and before the modeling process 100 is performed. However, in some embodiments, one or more parts of the calibration procedure are integrated into the kinetic model 160. Furthermore, in some embodiments, different sets of kinetic model parameters are applied at different stages of the simulation, as determined, for example, by the current value of the process variable 150a.
[0084] Experimental calibration data may include the concentrations of a set of metabolites at different time points. The cumulative calibration error to be minimized may be defined as:
[0085]
[0086] Among them [M k ] sim (t) is the simulated concentration of the kth metabolite at time t, [M k ] exp (t) is the experimental concentration of the kth metabolite at time t, and w k is the weight of the error of the k-th metabolite in the cumulative error. In this embodiment, the k-th metabolite error is calculated as the sum of the squares of the relative concentration errors at different times. In other embodiments, the error may be based on a combination of absolute concentration errors and relative concentration errors. The cumulative error is the weighted sum of the errors for each metabolite. The weights for different metabolites can emphasize the importance of some metabolite concentrations in calibration while suppressing or excluding other metabolite concentrations, and may depend on the experiment. For example, the concentration of glucose may be more relevant to experiments corresponding to the growth phase of a biological process, while the antibody concentration may be more relevant to experiments corresponding to the production phase. In general, various suitable experiments and error function formulas may be suitable for calibrating different kinetic model parameters.
[0087] The following discussion illustrates and provides the details of the exemplary embodiments of flux balance analysis 170. Flux balance analysis 170 uses constraints 164 (such as, for example, the maximum metabolite uptake rate, the minimum energy consumption rate maintained for the cell and the relevant minimum rate of target product production) generated by the kinetic model 160 to calculate a complete set of flux rates 174 for the metabolic model of cell biomass 130. Different metabolic models can consider different metabolites and different metabolic pathways. Each metabolic pathway flux can represent a reaction or a group of reactions, and this group of reactions converts a group of metabolites into another group of metabolites. The ratio of metabolic pathway flux consumption or production of metabolites forms a stoichiometric coefficient for the flux. Table 2 below illustrates an exemplary network of metabolic flux (as a model of CHO cells) configured for producing antibody products.
[0088] Table 2. Exemplary networks of metabolic pathway fluxes
[0089]
[0090] Subscripts distinguish between cytosolic or cellular metabolites (c), extracellular metabolites (e), and mitochondrial metabolites (m) that are part of cellular processes. Table 3 below lists and describes the metabolites that participate in the metabolic fluxes in Table 2.
[0091] Table 3. Metabolite definitions
[0092]
[0093] The flux balance analysis 170 of the modeling process 100 can calculate the flux rate for each of the metabolic pathways. Continuing the example of the metabolic network described in Table 2, the flux balance analysis 170 can determine the flux rate for each of the 34 metabolic pathways, which is affected by many conditions, restrictions, constraints or goals. One constraint for the calculation of flux can be a requirement to maintain the steady state of the metabolite concentration of the cell biomass 130. For example, the metabolic pathway 33 in Table 2 can convert hydrogen, reduced nicotinamide adenine dinucleotide and pyruvate into non-reduced forms of nicotinamide adenine dinucleotide and lactate in equal proportions indicated by a unified stoichiometric coefficient. Then, other metabolic flux sets can produce hydrogen, reduced nicotinamide adenine dinucleotide, and consume unreduced forms of nicotinamide adenine dinucleotide and lactate. As another example, the metabolic pathway 14 of Table 2 can produce hydrogen by taking hydrogen from the extracellular solution 124, or consume lactate by removing lactate into the extracellular solution 124, but may not be able to complete both at the same time. There may be no pathway for taking up pyruvate from or removing pyruvate to the extracellular solution 124, resulting in a requirement that may need to be balanced by intracellular pathway flux. In general, intracellular metabolite concentrations may be balanced at steady state by intracellular pathway flux or by interaction with the extracellular solution. Equation Steady-state conditions for flux balance analysis 170 are described, where is the stoichiometric matrix of the metabolic network, and the velocity vector is the vector of all flux rates. However, steady-state conditions may not be sufficient to find a unique solution to the flux balance analysis 170, and therefore, the flux balance analysis 170 may require other constraints 164 to limit the set of possible solutions.
[0094] Some of the metabolic pathways explain the removal of metabolites from cell biomass 130 or the uptake of metabolites from extracellular solution 124 into cell biomass 130. The flux balance analysis 170 steady-state solution can depend on the constraints for uptake or removal flux rate. For example, as discussed above with reference to the kinetic model 160, the uptake flux of substrate metabolites can be subject to the concentration of the corresponding metabolites in the extracellular solution 124 and the constraints of non-ideal environmental conditions. For example, for the metabolic network described in Table 2, as indicated by the metabolic pathway 5 of Table 2 (ignoring the extracellular oxygen input), oxygen can be present in the extracellular solution in large quantities. However, the maximum uptake rate of oxygen can be constrained by equation 12, which takes into account the maximum uptake rate for ideal conditions and the non-ideal condition correction factor indicated by the current value 150a of the process variable. In some embodiments, at least some of the metabolic flux rates corresponding to the metabolic pathways 3-17 of Table 2 are subject to the constraints of the rate constraints 164 calculated by the kinetic model 160. In other embodiments, the rate constraints 164 calculated by the kinetic model 160 are applied to the following intracellular metabolic pathways, which may be indirectly affected by extracellular conditions and uptake rates. For example, the glutamine constraint of equation 10 can limit the flux rate of metabolic pathway 27, the glucose constraint of equation 9 can limit the flux rate of metabolic pathway 34, and the asparagine constraint of equation 11 can limit the flux rate of metabolic pathway 25.
[0095] The flux balance analysis 170 may not be able to calculate a unique flux rate set for steady-state conditions under the constraints 164 generated by the kinetic model 160, and may additionally obtain at least one metabolic target 172 defined for the cell biomass 130. The metabolic target for the virtual cell biomass 130 in the computer simulation model 104 may correspond to the real biological target of the in vivo cell culture. A variety of metabolic objective functions may constrain the flux balance analysis 170 in different embodiments (representing different biological alternatives). The metabolic objective function 172 may maximize the growth rate of the cell biomass 130, minimize the linear combination of the metabolite uptake rate, maximize the flux rate of the path related to energy or ATP production, or generate another restriction for the flux rate set. Typically, the metabolic objective function 172 may calculate the flux rate represented by the velocity vector (such as the velocity vector of the metabolic network that can be represented by the velocity vector of the metabolic network). The cost or value of any set of (flux rate sets) represented by the flux balance analysis 170. In some embodiments, the flux balance analysis 170 minimizes the cost or value, while in other embodiments, the flux balance analysis 170 maximizes the cost or value. In addition, the metabolic objective function can depend on various current values 150a of the process variables, their history, and various other variables that describe the cell biomass 130 and its environment at the current time and at previously simulated times.
[0096] Considering the flux rates v1, v2, ...v N-1 , v N (These flux rates are velocity vectors The metabolic objective function 172 may take a variety of mathematical expressions, as exemplified in Table 4 below, for a set of N metabolic pathways or reactions (element of ), which may be a metabolic objective function. The table also provides an explanation and motivation for the metabolic objective function.
[0097] Table 4. Metabolic targets
[0098]
[0099] For a given metabolic objective function 172, the flux balance analysis 170 may not be able to find a solution that satisfies all constraints generated by the kinetic model 160. Specifically, if the constraint for the minimum rate of maintaining flux cannot satisfy the objective function 172 (the objective function maximizes the ratio of growth or growth to a function of other flux rates), the flux balance analysis 170 can switch to a different metabolic target 172, and may ignore the constraints of the minimum maintenance flux rate and the minimum production rate for the target product. For example, the flux balance analysis 170 can switch to a metabolic target 172 that maximizes the maintenance flux rate. After finding a steady-state solution that maximizes the maintenance flux rate, while satisfying the remaining constraints 164 (such as the maximum uptake rate), the flux balance analysis 170 can calculate the death rate or loss rate for the cell biomass 130 based on the difference between the ignored minimum maintenance flux rate and the maintenance flux rate achieved. The following death rate equation can be used to calculate the death rate equation, which represents the rate of change of biomass 130 relative to biomass concentration
[0100] v d =c d (v ATP,min -v ATP ) (Equation 17),
[0101] where v ATP,min -v ATP is the positive difference between the minimum sustained flux rate and the calculated deficit sustained flux rate, and c d is a scaling factor which is a parameter of the modeling process 100 .
[0102] The following discussion illustrates and provides details of exemplary embodiments of the rate integration module 180. Once the flux balance analysis 170 calculates the flux rate 174 (including the growth rate or death rate of the cell biomass 130), the rate integration module 180 can use the calculated flux rate 174 to calculate the updated value 150b of the process variable. The rate integration module 180 can perform a mass balance on the virtual contents of the bioreactor 120. Additionally or alternatively, the rate integration module 180 can calculate the consumption of the bioreactor 120 input (including substrate metabolites) and / or the production of target products.
[0103] The rate integration module 180 may first calculate the time rate of change of the process variable and then solve or numerically integrate the differential equation or the difference equation in discrete time form for the process variable. The equation for the time rate of change of the process variable may include contributions from the input stream 140 and the output stream 142. Some exemplary equations for a set of process variables are shown below. For example, a general equation for the time rate of change of a metabolite in an extracellular solution may be written as
[0104]
[0105] Among them [M e ] is the concentration of metabolites in the extracellular solution 124 (i.e., the process variable under consideration), [BIOM] is the concentration of biomass in the extracellular solution 124, is the extracellular metabolite M in the metabolic pathway flux i e The stoichiometric coefficient, v i is the flux rate calculated by flux balance analysis 170 for flux i, V is the volume of the extracellular solution 124, and F IN is the volume flow rate of the input stream 140, is the metabolite M in the input stream 140 (and the extracellular metabolite M e The concentration of the same substance, F OUT is the volume flow rate of the output flow 142, and T M is the transmission or selectivity factor of filter 144 for metabolite M. The expression is the total flux of all flux pairs in the metabolic network M e is the sum of the contributions of the extracellular concentration of M and when (correspondingly) only the uptake flux or only the removal (excretion) flux affects M e The extracellular metabolite concentration can be simplified to -v M or v M In embodiments of the modeling process 100 with multiple input streams, the sum of multiple terms representing the multiple input streams may replace The volume V can be a process variable whose rate of change is given by
[0106]
[0107] And in the embodiment where the volume is kept substantially constant, F IN =F OUT In some embodiments, there is no filter 144 for the output stream 142 and for each metabolite T M = 1, while in other embodiments, the filter does not substantially filter a given metabolite, resulting in a T M =1.
[0108] For a heterogeneous reactor, Equation 18 can represent the rate of change of a metabolite in a given portion of the bioreactor, and the equation can be adjusted to account for heterogeneity and mixing mechanics, as discussed herein. In some embodiments, particularly in embodiments with relatively fine spatial discretizations, the additional terms representing the input flow 140 and the output flow 142 can be replaced by the dot product of the concentration gradient of the metabolite and the velocity field. In a sense, this approach calculates the total derivative with respect to time based on the partial derivative with respect to time and the partial derivative with respect to the spatial dimension. In other embodiments, the additional terms representing the input flow 140 and the output flow 142 can be the result of adding flow contributions from adjacent portions of the heterogeneous bioreactor according to the velocity field. In some bioreactor volume discretizations, one portion can include input flows entering from outside the reactor, while another portion can include output flows from the reactor.
[0109] Returning to the discussion of the homogeneous bioreactor model, although, as discussed, the general applicability to heterogeneous bioreactors is not lost, Equation 18 may be modified to accommodate one or more specific metabolites. For example, consider an embodiment of the modeling process 100 in which the cell biomass 130 is modeled by the metabolic pathways in Table 2, wherein the input stream 140 and the output stream 142 have flow rates F IN =F OUT = F, the glucose concentration in the input stream 140 is And the perfusion configuration is T GLC =T ANTI =1 and T BIOM =0, the equation for the time rate of change of glucose concentration, biomass concentration and antibody product concentration can be:
[0110]
[0111] where v 15 is the flux rate of pathway 15 for glucose uptake, v 16is the flux rate of pathway 16 for antibody removal, and v 17 is the flux rate for pathway 17 for biomass removal. Although in some embodiments there may be no distinction between intracellular and extracellular biomass, the definitions in Table 2 distinguish between biomass production pathway 19 and biomass removal pathway 17, where the extracellular biomass concentration represents the cellular biomass 130 in the extracellular solution 124.
[0112] The rate integration module 180 can calculate the time rate of change of the cell biomass 130 based on the death rate or loss rate calculated in the flux balance analysis 170 as follows:
[0113]
[0114] where [BIOM] is the concentration of cellular biomass 130 in the extracellular solution 124, and v d is the death rate or loss rate calculated in the flux balance analysis 170. Although the biomass 130 may only account for the virtual living cell biomass with ongoing metabolic processes, in some embodiments, the concentration or amount of dead cells or dead biomass is another of these process variables that is updated by the modeling process 100. Any decrease in the virtual living biomass 130 represented by [BIOM] may result in a corresponding increase in the value of the process variable representing the dead biomass. Although the dead biomass may not have ongoing metabolic processes, it may still affect the properties of the extracellular solution 124.
[0115] Over the duration of the time period simulated by the modeling process 100, the rate integration module 180 can calculate the total amount of substrate metabolites supplied by the one or more input streams 140 and consumed by the cell biomass 130 and the total amount of products removed or collected by the one or more output streams 142. For example, the collected antibody product can be calculated using
[0116]
[0117] Where ANTI is the molar amount or mass of the collected antibody product, T ANTI is the time-varying transmission of the antibody through the output filter 144, F OUTis the time-varying flow rate of the output stream 142, and [ANTI] is the molar concentration or density of the antibody in the extracellular solution 124. The flow rate and transport can vary over time to represent different operating scenarios or simulate output filter performance, and can be represented by the following process variables, which are updated by the rate integration module 180. The operating scenario can represent an accumulation phase of the product in the extracellular solution 124 and a harvest phase that begins once the product concentration is at a sufficient level. In real bioreactor operation, separate accumulation and harvest phases can reduce the cost of separating the product from the output stream 142. The filter transfer function T ANTI It may represent a step change in transmission when the filter 144 is replaced or a gradual change in transmission due to some filtered metabolites or other components of the output stream 142 remaining.
[0118] In some embodiments, the rate integration module 180 can calculate the stress of changes in temperature, pH and / or other process variables on the cell biomass 130. These changes in process variables can depend on the control variables 152. In some embodiments, the control variables 152 are processed by the flux balance analysis 170 and / or the rate integration module 180. Stress can accumulate over time, which makes the rate integration module 180 suitable for calculating updated process variables, which indicate stress. Additional process variables can contribute to the calculation of stress. For example, the temperature memory variable can indicate the time evolution of the impact of the temperature of the cell biomass 130 to maintain the energy demand.
[0119] The rate integrator module 180 may use the calculated time rate of change for the metabolite concentration to calculate an updated value for the corresponding process variable for the concentration based on the current value of the process variable as follows:
[0120]
[0121] Among them [M e ] n+1 may represent the updated value of the extracellular concentration of metabolite M after the (n+1)th time step 102 of the modeling process 100, [M e ] n can represent the current value after the nth time step 102, is the calculated derivative, and Δt n+1 is the duration of the (n+1)th time step.
[0122] For heterogeneous reactors, The total derivative for a portion of the bioreactor may be represented, the total derivative being calculated, for example, from a concentration gradient and a velocity field, as discussed above. The velocity field may be updated at each time step 102, which may be more frequent than the time step 102 or less frequent than the time step 102. The velocity field may be updated in response to a trigger condition in the simulation. For example, a change in the flow rate of a simulated flow supplying the bioreactor, a change in the simulated mixing of the bioreactor, or a substantial change in a physical property of the contents of the bioreactor may trigger a new calculation of the velocity field.
[0123] In some embodiments, the duration of each time step 102 remains constant, while in other embodiments, the modeling process may vary the duration of the time step 102 for different values of n. The variation in the duration of each time step 102 may depend, for example, on the calculated flux rate 174, the flow rate of the input stream 140 or the output stream 142, the control variables 152, and / or requirements regarding the speed or accuracy of performing the modeling process 100.
[0124] The rate integrator module 180 may use one or more of a variety of techniques for integrating the derivative or rate of change of the process variable to implement a process variable update formula other than Equation 24. The rate integrator module 180 may use first order, second order, or higher order methods, including the Euler method, the Runge-Kutta method, the backward differentiation formula, the exponential integration technique, or other suitable methods.
[0125] When the process variable corresponding to the simulated virtual time indicates the end of the simulated time period, the iterative portion of the modeling process 100 can end. In an embodiment, the new / updated value of the process variable calculated by the modeling process 100 in each iteration of the time step 102 can be stored or saved for further calculation or processing. For example, the values calculated at different virtual times or different iterations of the virtual time step 102 can be combined to create a data set that indicates the time evolution of the process variable.
[0126] After completing the iterative portion performed for the sequence of time steps 102, the modeling process 100 may include an additional module for calculating one or more metrics of the computationally modeled bioreactor 120 based on the new values of the calculated process variables. One of the one or more metrics can be a numeric value or a collection of numeric values in a vector, array or other suitable data structure, a text value or a collection of text values in a suitable data structure, or a Boolean value or a collection of Boolean values in a suitable data structure. The metric can indicate the quality of the simulation and the confidence of the output, or it can be a measure of the performance of a hypothetical real bioreactor corresponding to the simulation. For example, the metric can indicate the efficiency of converting a substrate metabolite into a target product, where the efficiency is calculated in terms of financial cost and / or time. Additionally or alternatively, the metric can indicate the total amount of the target product produced and / or the quality of the product.
[0127] The modeling process 100 may include additional modules for generating information based on the measurements of the modeled bioreactor (which information is displayed to the user via a user interface), control settings for a real-world bioreactor, and / or a training set for an artificial intelligence model of a hypothetical real-world bioreactor that is operationally similar to the simulated bioreactor 120.
[0128] Figure 2 Graph 200 is included that depicts an exemplary effect of temperature variation on a calculated stress variable in an embodiment of modeling process 100. Graph 200 has a horizontal time axis 202 that represents increasing time from left to right as simulated by modeling process 100. A vertical temperature axis 204 corresponds to a solid trace labeled T and a dashed trace. SOL , represents the temperature of the extracellular solution 124; the dashed trace is marked as T MEM , representing memory temperature, while the other vertical axis 206 corresponds to a dot-dashed line trace, labeled stress, representing the stress variable discussed above.
[0129] Still refer to Figure 2 , the simulation performed by the modeling process 100 may begin with the following process variables for the temperature T of the extracellular solution 124 at level T1 SOL , no substantial stress is introduced to the virtual biomass 130 at level T1. Level T1 may correspond to an optimal temperature for the growth of the cell biomass 130. At a certain time (in t s), the temperature of the solution 124 may drop to a lower level T2 that is below the optimal temperature for the cell biomass 130. The drop in temperature may occur in response to one of the control variables 152 and may be abrupt, as shown in the graph 200, or may be more gradual. SOL The sharpness of the temperature change can depend on the modeled control mechanism for the bioreactor 120, including the speed and quality of the mixing of the modeled bioreactor contents. Even for the sharp change in temperature shown in the graph 200, the memory temperature T sensed by the biomass 130 is MEM The change may be more gradual still (explaining the biological response to temperature shifts) and may follow a time evolution represented by the following equation:
[0130]
[0131] where k temp is a model parameter that corresponds to the speed at which the cell biomass 130 adapts to temperature changes. The rate integration module 180 can calculate T by integrating Equation 25. MEM (t), and T can be calculated by using the following equation MEM With T SOL The area between the stress
[0132]
[0133] The results are represented by the dotted line on the graph 200 which represents stress.
[0134] Figure 3 An exemplary computer system 300 is shown upon which the methods and techniques described herein may be implemented. Figure 3The computer system 300 includes a computer 310. The components of the computer 310 may include, but are not limited to, one or more processors 312, which are connected to the system memory 330 through a system bus 320. The one or more processors 312 may include one or more single-core or multi-core central processing units (CPUs), graphics processing units (GPUs), or any other suitable processor architecture. For example, the system memory 330 may include a read-only memory (ROM) component and a random access memory (RAM) component. The RAM component of the system memory 330 may be any of several types of RAM, including static RAM (SRAM), dynamic RAM (DRAM), synchronous dynamic RAM (SDRAM), double data rate SDRAM (DDR SDRAM), or another suitable type of RAM. The system bus 320 may include one or more types of bus structures (including a memory bus or memory controller, a peripheral bus or a local bus, etc.), and any suitable bus architecture may be used. By way of example and not limitation, such architectures include an industry standard architecture (ISA) bus, a microchannel architecture (MCA) bus, an enhanced ISA (EISA) bus, and a peripheral component interconnect (PCI) bus (also known as a mezzanine bus).
[0135] The one or more processors 312 may also be communicatively coupled to one or more peripheral devices and network interfaces 340 and internal non-volatile memory 342 via the system bus 320. For example, the internal non-volatile memory may be, for example, a hard disk drive (HDD) or a solid state drive (SSD). Additionally or alternatively, an external non-volatile memory device 344 may be communicatively coupled to the computer 310 via the peripheral and network device interface 340. The peripheral and network interface 340 may include various connectors or adapters for communicatively coupling to devices external to the packaging or housing of the computer 310.
[0136] The peripheral and network interface 340 may include one or more universal serial bus (USB) interfaces, one or more video connections, including but not limited to VGA (video graphics array), DVI (digital visual interface) and / or HDMI (high-definition multimedia interface). The peripheral and network interface 340 may be connected to one or more user interface devices 350, including but not limited to a display 352, a keyboard 354, and a mouse 356. In some embodiments, some or all of the user interface devices 350 are integral with the computer 310 and may be communicatively connected to the one or more processors 312 via the bus 320. Additionally or alternatively, the display 352, keyboard 354, and mouse 356 may be integrated into a touch screen.
[0137] Additionally or alternatively to connecting to the user interface device 350, the peripheral device interface 340 can be communicatively connected to one or more external non-volatile memory devices 344. The non-volatile memory devices 344 can include HDDs, SSDs, and removable storage drives for optical, magnetic, or electronic media, including but not limited to compact discs (CDs), digital versatile discs (DVDs), tapes, floppy disks, or flash memory. Additionally or alternatively, the peripheral device and network interface 340 can be communicatively connected to output devices, including but not limited to printers, plotters, speakers, or any other suitable visual, auditory, tactile, or haptic output devices.
[0138] Peripheral and network interface 340 may include one or more network adapters to communicatively connect to one or more networks (not shown), which may include a local area network (LAN) and / or a wide area network (WAN), such as the Internet. The connection may be a wired connection or a wireless connection such as using, for example, radio signals or optical signals. Through the connected network, computing system 300 may be communicatively connected to other computing systems, peripherals, or other devices.
[0139] Collectively, the one or more processors 312, bus 320, system memory 330, peripherals and network interface 340, internal non-volatile memory 342, external non-volatile memory device 344, and user interface device 350 may be referred to as the processing hardware of computing system 300. Figure 1 The processing hardware for implementing the modeling process 100 may be omitted. Figure 3 Some of the elements depicted in, or include additional elements.
[0140] In operation, computing system 300 may load program instructions into system memory 330 for execution by one or more processors 312. For example, the system may load program instructions from internal non-volatile memory 342 or from external non-volatile memory device 344 into system memory 330. The program instructions loaded into system memory may include operating system 362, and various application programs 364. In some implementations, computing system 300 may enable other computing systems to be communicatively connected to computing system 300 to load program instructions for execution by processors of other computer systems.
[0141] The application programs 364 loaded into the system memory 330 of the computer 310 may include a bioreactor simulation program 365 that contains instructions for at least partially implementing the bioreactor simulation program using the processing hardware of the computing system 300. Figure 1Instructions for the modeling process 100 of the computer system 300. In some embodiments, other computing systems in communication with the computing system 300 can use the processing hardware of the other computing systems to implement portions of the modeling process 100. The application programs 364 loaded into the system memory 330 of the computer 310 can additionally include a user interface implementation program 366 that configures the hardware of the computing system 300 to implement portions of the modeling process 100 in various ways or to facilitate or enhance the implementation. For example, the user interface implementation program 366 can configure the hardware to receive multiple current values 150a of process variables, control variables 152, and / or input and output flow variables 182 at the beginning of a simulation or in some embodiments during a simulation. Additionally or alternatively, the user interface implementation program 366 can configure the hardware to display information to a user via a user interface presented, for example, on the display 352.
[0142] The user interface implementation program 366 can configure the hardware to display information to the user in various ways. In this context, displaying information can mean presenting information in visual form on the display 352, or presenting information on printed paper, or presenting information in audio form through a speaker, or presenting information in tactile or tactile form through a tactile or tactile device, or presenting information in various other suitable ways. The user receiving the displayed information can be a scientist, a bioreactor operator, or any other personnel interested in the displayed information. In some embodiments, the user is another machine that can process the displayed information and initiate an action based on the processed information. In some embodiments and / or scenarios, the user receiving information by at least one of the user interface devices 350 and the user inputting information by at least one of the user interface devices 350 are different users.
[0143] Returning to the application 364 (which may include the bioreactor simulation program 365 and the user interface implementation program 366), in operation, the application 364 may access and modify the program data 368 portion of the system memory 330. The program data 368 may include data received at the beginning of the simulation and all new data calculated throughout the simulation. The program data 368 may include, for example, all or some of the following examples: current values of process variables 150a, updated values of process variables 150b, control variables 152, and / or input and output flow variables 182. The program data 368 may include indicators or values of time steps 102, as well as other time parameters of the simulation. Other time parameters may include, for example, a virtual start time, a virtual end time, and various virtual transition times, such as t s (Right now, Figure 2In addition, the program data 368 may include one or more measurements of the computationally modeled bioreactor 120 (based on the calculated new values of the process variables), and generated output information (based on the one or more measurements). The generated output information may include information intended to be displayed to a user via a user interface (which is presented in one or more of the user interface devices 350), or a training set of an artificial intelligence model for the target bioreactor, such as for storage in the internal non-volatile memory 342 or the external non-volatile memory device 344.
[0144] In some embodiments, the bioreactor simulation program 365 and the user interface implementation program 366 are part of a single application. In other embodiments, the bioreactor simulation program 365 and the user interface implementation program 366 are independent applications that share the hardware resources of the computer 310 simultaneously or sequentially. For example, the user interface implementation program 366 can present a user interface on the user interface device 350 to receive data necessary for the bioreactor simulation program 365 and store the data in the internal non-volatile memory 342 or the external non-volatile memory device 344. At different times, the bioreactor simulation program 365 can use the data stored by the user interface implementation program 366 (or by another application) to implement the bioreactor modeling process 100 and store any generated metrics or other output data in the internal non-volatile memory 342 or the external non-volatile memory device 344. At a later time, the user interface implementation program 366 can retrieve the output of the bioreactor simulation program 365 and generate appropriate output for the user.
[0145] Figure 4A and 4B Two panels of an exemplary user interface 400 are shown, which may be presented on display 352 by, for example, a user interface implementation program 366 running on computer 310. User interface 400 may enable the modeling process (e.g., Figure 1 The exemplary modeling process 100 of the embodiment of the present invention can receive at least some of the initial values of the process variables (e.g., the current value 150a for the first time step 102). To this end, the exemplary user interface 400 may include one panel 410 for receiving experimental condition variables from a user and another panel 412 for receiving medium composition variables from a user, wherein the user enters information via the user interface device 350 (e.g., the keyboard 354 and the mouse 356). Figure 4AThe experimental condition panel 410 may contain input units 422a-422m (wherein the user may enter numerical values for specified initial values of process variables) and buttons 424a-424m, which may be activated by the user by clicking buttons on the mouse 356, causing the corresponding values to be loaded into the program data 368.
[0146] Some of the values entered in the experimental conditions panel 410 may set the values of the control variables 152 in the modeling process 100. For example, the filter change 422d, harvest time 422f, and glucose injection time 422m may indicate virtual times within the simulated time interval when the process variable may change based on virtual control rather than by updating the process variable by integrating the calculated rate of change.
[0147] Figure 4B The medium composition panel 412 in the modeling process 100 enables the modeling process 100 to receive initial process variable values from the user through input units 432a-432h, which are indicative of metabolite concentrations in the batch medium or the extracellular solution 124 in the batch mode of the bioreactor 120, and / or receive metabolite concentrations in the input stream 140 from the user through input units 442a-442h during the perfusion mode of operation of the bioreactor 120. Once a simulation time interval corresponding to the perfusion mode begins, the concentration of the metabolite in the input stream 140 can begin to affect the process variable corresponding to the concentration of the metabolite in the extracellular solution 124 by changing the corresponding rate of change calculated by the rate integration module 180.
[0148] Figure 5 An exemplary user interface 500 for displaying information to a user is shown. For example, Figure 3 The user interface implementation program 366 of the present invention can present the user interface 500 on the display 352. The user interface implementation program 366 can generate information required for displaying the user interface 500 based on the measurement calculated by the bioreactor simulation program 365, and display the information in the panel 510a-510e. The displayed measurement can include traces 512a-512f, which represent the values of multiple process variables during the simulated time period. The user can select the variables to be displayed through another user interface provided by the user interface implementation program 366. In addition or alternatively, the user can choose to display another set of traces 514a-514f, which represent the values from the previously simulated time period. The traces 512a-512f, 514a-514f from the two simulations can reflect different process conditions, which can be input by the user, for example, through the user interface 400.
[0149] In one example, the panels 510a-510e of the user interface 500 display the trace 512a of the biomass variable, the trace 512b of the lactate variable, the trace 512c of the glucose variable, the trace 512d of the ammonia variable, the trace 512e of the permeate variable, and the trace 512f of the antibody variable, respectively. The comparison provided by the corresponding 514a-514f traces from the previous simulation can provide the user with useful information about the expected change of the assumed bioreactor operating performance without the need to conduct in vivo experiments with the real-world bioreactor. The permeate traces 512e, 514e can indicate, for example, the virtual time evolution of the concentration or amount of the antibody product in the process of several days, which is harvested from the output stream 142. The sharp increase from the zero baseline of the permeate traces 512e, 514e can correspond to the virtual harvest starting at the virtual time, which is input into the harvest time of the input unit 422f for the user interface 400A. The start of harvest may also correspond to a change in operation of the simulated bioreactor 120 from batch mode to perfusion mode, or a change in the virtual filter 144 that controls the amount of target antibody product in the output stream 142, and a corresponding change in the calculation of updates to the antibody concentration variable by the rate integration module 180. Thus, as the simulation of harvest begins, traces 512f, 514f begin to decrease, which are indicative of the antibody concentration in the extracellular solution.
[0150] Traces 512a, 514a for biomass may indicate two distinct regions: a high growth rate region and a subsequent slower growth region. The transition between these two regions may correspond to the introduction of stress, for example, by: s The temperature of the extracellular solution is lowered from T1 to T2 (e.g. Figure 2 422i of the user interface 400A. The changes corresponding to the temperature variations of the metabolic byproduct traces 512b, 514b, 512d, 514d for lactate and ammonia can indicate a decrease in lactate production and an increase in ammonia production, as calculated by the flux balance analysis 170 of the modeling process 100. The variability of the first half of the glucose traces 512c, 514c can correspond to the introduction of glucose injection into the input flow stream 140, based on the values entered in the input cells 422l-422m of the user interface 400A. In an exemplary embodiment, the traces presented in the panels 510a-510f represent the interdependence of the process variable values, which are calculated by the applications 365, 366 running on the computing system 300 using the modeling process 100.
[0151] Figure 6The bioreactor control system 600 is shown in an embodiment in which one or more programs for modeling a bioreactor (e.g., the bioreactor simulation program 365 and / or another application) cause the processing hardware of a computer 610 to generate control settings for a real-world bioreactor 620. For example, the computer may be Figure 3 310 in the bioreactor, and control settings may be communicated through one of the interfaces of the peripheral and network interface 340. In addition to the real-world bioreactor 620, the bioreactor control system 600 also includes a controller 630 and one or more sensors 640. The controller 630 may be in communication with the one or more sensors 640, which sense, measure, and / or convert physical, chemical, and biological properties of the bioreactor 620 and any connected systems. The sensors 640 may measure, for example, the weight of the bioreactor 620, the liquid level within the bioreactor 620, the temperature at multiple locations, the acidity, turbidity, optical density, osmolarity, oxygen level, the concentration of various metabolites, the chemical composition of solid liquid or gas samples, cell counts, and any other suitable indicator of the performance or operation of the bioreactor 620 and / or components fluidically or mechanically connected to the bioreactor 620.
[0152] The controller 630 can control various mechanical and / or electrical components, including one or more heaters or heat exchangers, one or more mixers, converters, pumps, valves, and / or other devices for changing the physical, chemical, and biological properties of the bioreactor 620 and its contents, through one or more communication, electrical, or mechanical connections. In some embodiments, the controller 630 controls one or more quantities (e.g., temperature, glucose concentration, etc.) associated with the bioreactor 620 using respective proportional-integral-derivative (PID) controller hardware, firmware, and / or software. For example, the controller can cause a change in the input flow rate or composition of the flow entering the bioreactor 620, and / or a change in the temperature of the contents of the bioreactor 620. The controller can cause changes in the operating mode of the bioreactor 620, including, for example, switching from a batch operating mode to a continuous flow operation to a perfusion mode, a change from a high growth rate mode under substantially optimal conditions for cell growth to a stressed mode for increasing the yield of a target product, a change from a production mode to a harvesting mode, and / or any other desired change. The controller 630 may take any of the above actions in response to one or more control settings communicated to the controller 630 by the computer 610. Additionally or alternatively, the controller 630 may communicate a signal from the sensor 640 to the computer 610. The computer 610 may use the signal from the sensor 640 to implement the modeling process 100. For example, the computer 610 may adjust one or more modeling parameters of the model 104 based at least in part on the sensor signal received from the controller 630. In some embodiments, the sensor 640 is in direct communication with the computer 610. In some embodiments, the computer 610 is Figure 3 In some embodiments of the computer 310, a user may input values indicative of sensor signals through the user interface device 350 or through the external non-volatile memory device 344. In some embodiments, the controller 630 implements model predictive control (MPC) to control mechanical and / or electrical components.
[0153] Regardless of whether signals from the sensor 640 are used in implementing the modeling process 100, control settings generated by the computer 610 and based at least in part on the measurements of the computationally modeled bioreactor 120 can be used to change the operation of the real-world bioreactor 620 via the controller 630. For example, the modeling process 100 implemented on the computer 610 can calculate the measurements indicative of the optimal time to change the mode of operation and send the corresponding control settings to the controller 630. In some embodiments, the computer 310 and the computer 610 are different devices that are communicatively connected to each other, and the control settings are generated by the computer 310. For example, the control settings can be transmitted to the computer 610 via a network through one of the peripheral device and network interface 340, or through one of the external non-volatile memory devices 344. In some embodiments, the control settings for the real-world bioreactor 620 are part of a real-time model-based control of the bioreactor 620. In other embodiments, the control settings are based on measurements generated by the model at a previous time as part of a computer simulation experiment related to the operation of the real-world bioreactor 620.
[0154] Figure 7 is a flowchart depicting a computer-implemented method 700 for computationally modeling a bioreactor according to an example embodiment. For example, the method 700 may be applied Figure 1 The computational model 104 may include Figure 1 In addition, the method 700 can be implemented by one or more processors 312 of the computer 310 (e.g., when executing the bioreactor simulation program 365), or another suitable computing device or computing system. The method 700 can be suitable for modeling a spatially heterogeneous bioreactor using, for example, the above-mentioned techniques.
[0155] Method 700 includes receiving a plurality of current values of process variables (block 710). These values may be received from a user via a graphical user interface, such as Figure 4A and 4B and as exemplified in the related discussion. Figure 6 As presented in the related discussion, in some embodiments, the received value can be based on measurements of an actual bioreactor. Additional or alternative ways of receiving or obtaining a current value of a process variable can include loading a value (e.g., a previously calculated value) from a computer memory and / or loading a predetermined default value from a computer memory.
[0156] For example, the process variables received at block 710 may describe the virtual contents of a bioreactor, such as Figure 1124) of the bioreactor 120 modeled in the process variables. The process variables may include, for example, one or more variables describing the temperature, acidity, and / or indicating the total osmotic volume of the extracellular solution (e.g., extracellular solution 124), biomass (e.g., biomass 130), and / or input and output streams (e.g., input stream 140 and / or output stream 142) of the extracellular solution. Additionally or alternatively, the process variables may indicate the amount or concentration of the virtual biomass (e.g., biomass 130) and / or the amount or concentration of any one of the metabolites in the virtual extracellular solution (e.g., solution 124), and / or the input and output streams (e.g., input stream 140 and / or output stream 142). Metabolites having amounts or concentrations described by process variables may include oxygen, carbon dioxide, ammonia, lactate, glucose, asparagine, glutamine, glycine, and / or any other suitable metabolite. The variables may describe the amount or concentration of metabolites outside the cell and / or inside the cell (inside the virtual cell). In some embodiments, the process variables describe metabolite concentrations in different cellular organelles or cellular apparatus. Additionally, when the method 700 models a heterogeneous bioreactor, the process variables can describe each of the modeled bioreactor portions.
[0157] To calculate new values of the process variables during the simulated time period, the method 700 may generate a plurality of constraints on the flux rate of the metabolic flux (e.g., describing the virtual cell biomass 130) for each given time step (e.g., multiple iterations of the time step 102) at block 720. The metabolic flux may be Figure 1 The fluxes depicted in 132a-132i, the fluxes listed in Table 2, or any other suitable description of metabolic pathways and / or biochemical reactions in a cell metabolic process. Metabolic fluxes can describe the metabolic networks of different types of cells, including bacterial cells, animal cells, and / or fungal cells. Cell types modeled by cell biomass can include stem cells or germ cells (e.g., Chinese hamster ovary (CHO) cells).
[0158] Method 700 can generate constraints for flux rate by: using a kinetic model (such as, for example, kinetic model 160), at least some of the current values of process variables (e.g., current values 150a) are modeled for one or more effects on metabolic reaction kinetics. The constrained flux rate can include glucose uptake, glutamine uptake, asparagine uptake, oxygen uptake and / or any other flux rate that is directly or indirectly restricted by extracellular conditions (e.g., conditions of extracellular solution 124) at the higher end and / or at the lower end. For example, restrictive conditions can include temperature, acidity and / or osmotic pressure. Constraints for metabolic flux rate can include upper and / or lower limits for flux rate for biomass growth or energy consumption for cell maintenance. Modeling the one or more effects of these current values of these process variables on metabolic reaction kinetics can include calculating the influence of temperature, acidity, and / or osmotic pressure on the upper limit of metabolite uptake rate by multiplying the upper limit under ideal conditions with a correction factor, and the correction factor indicates that the uptake rate is reduced due to non-ideal conditions. Correction factors can be constructed in light of experimental observations of real-world cell cultures that are subject to varying conditions. These and other experimental observations can be included in a calibration procedure for a computational model, such as computational model 104.
[0159] The effect of the current value of the process variable on the metabolic reaction kinetics can include the effect of stress on the lower limit of the energy consumption rate maintained by the cell. The stress surge can be used to induce a higher production rate of the target product. In one embodiment, if Figure 2 As shown in , temperature fluctuations can induce stress, requiring cell biomass to consume more energy on non-growth processes. Other ways of inducing stress in cell biomass can be to change the acidity or osmotic pressure of the extracellular solution. The current value of process variables can include the influence of metabolic byproducts on the impact of metabolic reaction dynamics. Lactate concentration and ammonia concentration can be among the following factors, which affect the constraints of the flux rate calculated by the kinetic model. Modeling the above-mentioned impact can include calibrating the modeled impact with experimental data from real-world cell culture.
[0160] Method 700 can continue to calculate the flux rate of metabolic flux (for example, for virtual biomass 130) by performing flux balance analysis (for example, flux balance analysis 170) at frame 730. Flux balance analysis may be affected by metabolic target (for example, metabolic target 172) and multiple constraints (for example, constraint 164) generated for flux rate. Some exemplary metabolic targets are listed in Table 4 above. By seeking minimum value for the ratio of at least some linear combinations in flux rate and the square of flux rate, a wide range of metabolic targets can be generated. Each weight in the linear combination can be positive, negative or zero. Therefore, the metabolic target generated can, for example, effectively maximize the growth of every total flux ratio, or maximize the growth consumed relative to substrate metabolites. For example, in the scenario of maintaining insufficient energy, non-negative growth may not be achieved, and maximizing energy to maintain can be the metabolic target used in flux balance analysis. When maintaining energy enough, maximizing the growth rate of virtual biomass can be the metabolic target used in flux balance analysis.
[0161] At block 740, the method 700 may calculate a rate of change of at least some of the process variables based at least in part on the flux rate calculated at block 730. Calculating the rate of change may include receiving one or more variables indicative of a flow rate and a constituent input flow (e.g., a flow variable 182 corresponding to the input flow 140), an output flow (e.g., a flow variable 182 corresponding to the output flow 142), and / or an output filter (e.g., a filter 144).
[0162] The method 700 may then update one or more of the current values of the process variables (e.g., the current values 150a) at block 750 at least in part by integrating one or more of the rates of change calculated for the duration of the virtual time step. This may end the iteration for a given virtual time step. For example, the updated value at the end of one time step may become the current value used for the next time step. For example, when calculating the updated value 150b from the current value 150a, block 750 may be performed by Figure 1 The method 700 may be performed by the rate integration module 180 of the virtual output flow. The method 700 may calculate the update value (using, for example, the rate integration module 180) at least in part by considering the following variables, which indicate the flow rate and composition of the input and / or output flow. At block 750, the method 700 may include the flow variables in the mass balance difference or differential equation discussed above and solve the equation by integration. Additionally or alternatively, the mass balance equation may include the effect of the following variables on the composition of the virtual output flow, which variables indicate the properties of the virtual output filter.
[0163] When the method 700 models a heterogeneous bioreactor, the method can include updating process variables for each portion of the modeled bioreactor based at least in part on the calculated velocity field. The velocity field can be calculated, for example, using a CFD model. The method 700 can update process variables for a portion of the bioreactor in view of process variables for adjacent portions of the bioreactor. In some embodiments, the method 700 can define gradients for at least some of the process variables in at least some of the modeled portions of the bioreactor.
[0164] Before continuing to box 760, method 700 can iterate boxes 710-750 for part or all of the simulated time period, and the simulated time period is divided into a sequence of time steps. In other embodiments, box 760 occurs in parallel with the following iterations, which are related to one or more of boxes 720-750. At box 760, the new value of the process variable calculated during any virtual time step or step is used to calculate a measure of the modeled bioreactor, or more generally, a model of a system containing a virtual bioreactor (e.g., model 104). This measure of the computationally modeled bioreactor can indicate the effectiveness or efficiency of the computationally modeled bioreactor in producing a target product. For example, a measure can indicate total product output, yield with respect to energy and / or substrate metabolites, productivity of the reactor, and / or quality of the target product. In some embodiments, multiple measures are calculated at box 760. Additionally or alternatively, one or more measures may include the value of at least one of the process variables at different virtual times within the simulated time period, such as, for example Figure 5 and the related description. For a heterogeneous bioreactor, the metrics calculated for each portion of the bioreactor can contribute to the metrics of the overall bioreactor. However, in some embodiments, the bioreactor metrics can be based on one or more portions of the bioreactor, including the output stream flowing out of the bioreactor. Additionally or alternatively, at block 760, method 700 can generate a metric that indicates heterogeneity within the bioreactor.
[0165] At block 770 of method 700, information may be generated and displayed to a user via a user interface presented, for example, on a display (e.g., display 352). Method 700 may generate the displayed information based at least in part on the metrics calculated at block 760. In some implementations, block 770 may additionally or alternatively include generating a display for, for example, Figure 6and control settings of a real-world bioreactor (e.g., bioreactor 620) depicted in the accompanying description. In some embodiments, method 700 is integrated into a model-based control scheme of a real-world bioreactor (e.g., using model predictive control). When a heterogeneous bioreactor is modeled, method 700 can display the heterogeneity at a user interface or generate one or more control settings based on, for example, a calculated measure of heterogeneity. For example, mixing can be initiated or enhanced when a measure indicating heterogeneity exceeds a threshold.
[0166] Additionally or alternatively, block 770 may include generating a training set for an artificial intelligence model for a bioreactor by using the measurements calculated at block 760 as ground truth labels for a bioreactor model, wherein the model is described by a set of parameters. Multiple executions of method 700 may allow for the accumulation of multiple data sets of model parameters and corresponding measurements. The data sets may be used to train an artificial intelligence model based on a neural network, a convolutional neural network, a decision tree, a clustering algorithm, and / or other suitable machine learning techniques. The trained artificial intelligence model may then estimate or predict new measurements based on the bioreactor model parameters without having to execute computational modeling method 700 again.
[0167] Figure 8 An example evolution of process variables and metrics calculated using method 700 is shown. A data set for initial process variables (including pH, temperature, medium composition) and a medium feed schedule (input streams) for a monoclonal antibody production process are received. Figure 1 and 7 The process was computationally modeled using the workflow presented in and described above. The values of the process variables (in arbitrary units) corresponding to the metabolite concentration (CC-GLC, as defined in Table 3), as well as the measures of cell viability, viable cell density (VCD), and antibody production (titer) calculated by the model are presented in Figure 8 are plotted as solid lines. Values of metabolite concentrations, viable cell density (VCD), cell viability, and antibody titers measured during real-world execution of the same production process are plotted as points on the same scale as the corresponding calculated values. The computational model largely predicted the observed real-world process performance. The dramatic changes in some metabolite concentrations are due to discontinuous feeding of the bioreactor - metabolites are added in batches at specific times of the day. The lack of dramatic changes in the measured metabolites is due to the fact that measurements are restricted to the time of day before the addition of the feed metabolites. The measure of viability (VIAB) represents the fraction of cells in the biomass that are still able to produce product and depends on the cumulative effect of cell death, as described above. VCD then represents the biomass concentration multiplied by the viability.
[0168] Fig. 9A and 9B Schematically illustrated is an example method for modeling spatial heterogeneity in a bioreactor 900. The bioreactor 900 can include an impeller 905 or another mixing device configured to mix the bioreactor contents. Fig. 9A An example of partitioning a bioreactor 900 into a plurality of sections 910a-910d is shown. A homogeneous metabolic model (e.g., model 104) can represent each of sections 910a-910d. Each of sections 910a-910d can share boundaries with one or more other sections. In the example shown, section 910c is completely disposed within section 910d, while section 910d borders all other three sections (i.e., 910a-910c). The inlet and outlet (not shown) into the bioreactor 900 can add metabolites to the modeled sections 910a-910c or remove metabolites from these sections. For each of sections 910a-910d, the modeled input and output flows (e.g., flows 140, 142) can include virtual contents due to the flow of the inlet and outlet and the flow across the boundaries with adjacent sections. The flow of virtual contents across the boundaries between bioreactor sections 910a-910d can follow Fig. 9B Calculating the input and output flows may include estimating the gradient of the process variable across the boundaries (the gradient being the respective difference in the value of the process variable in the region forming the boundary), integrating the velocity field 920 across each boundary (and orthogonal to the boundary), and multiplying the estimated gradient by the integrated value of the velocity field 920 corresponding to each boundary.
[0169] Fig. 9B The velocity field 920 is shown as a set of dashed arrows. The CFD model can calculate the velocity field 920 based on a volume discretization of the bioreactor 900 and a suitable computational technique. In some embodiments, the method of computationally modeling the bioreactor 900 (e.g., method 700) can determine the velocity field 920 based at least in part on measurements (e.g., particle velocimetry) or a combination of pre-computed or measured velocity fields. The velocity field 920 can depend on the geometry of the bioreactor 900 and the impeller 905, as well as the speed of the impeller 905. The velocity field 920 can also depend on the input and output flows of any inlet and outlet of the bioreactor 900. Importantly, under a set of static conditions, the velocity field 920 can have a stable state from which the model can calculate the flow of virtual contents across the boundaries between the bioreactor sections 910a-910d. Additionally or alternatively, a coupled fluid dynamics and metabolic model can account for the dynamic changes in the velocity field 920 and the corresponding effects on the evolution of metabolite concentrations in the bioreactor sections 910a-910d.
[0170] The following list of options reflects the various embodiments expressly contemplated by this disclosure.
[0171] Option 1. A method of computationally modeling a bioreactor, wherein the method comprises:
[0172] receiving a plurality of current values of process variables describing virtual contents in at least a portion of the modeled bioreactor, and the virtual contents including virtual cellular biomass in a virtual extracellular solution;
[0173] New values of the process variables during the simulation time period are calculated by processing hardware of the computing system at least in part by:
[0174] generating a plurality of constraints on flux rates describing metabolic flux of the virtual cell biomass by modeling one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics,
[0175] The flux rates of the metabolic fluxes are calculated by performing a flux balance analysis that is influenced by the metabolic target and the multiple constraints generated for the flux rates.
[0176] calculating a rate of change of at least some of the process variables based at least in part on the calculated flux rate, and
[0177] updating one or more of the current values of the process variables at least in part by integrating one or more of the calculated rates of change for virtual time steps within the simulation time period;
[0178] calculating, by the processing hardware, metrics of the computationally modeled bioreactor based at least in part on the calculated new values of the process variables; and
[0179] One or more of the following is generated by the processing hardware and based on the measurements of the modeled bioreactor: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of the bioreactor.
[0180] Option 2. The method of Option 1, wherein the process variables include at least one of: temperature, acidity, or one or more variables indicative of total osmolarity of the virtual contents.
[0181] Option 3. The method of any of Options 1-2, wherein the process variables include one or more variables indicative of the concentration of the virtual cellular biomass and one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution.
[0182] Option 4. The method of Option 3, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include one or more variables indicative of the concentration of at least one of: oxygen, carbon dioxide, or ammonia.
[0183] Option 5. The method of any of Options 3-4, wherein the one or more variables indicative of the concentration of an extracellular metabolite in the virtual extracellular solution include variables indicative of the concentration of one or more of: glucose, asparagine, glutamine, or glycine.
[0184] Option 6. The method of any one of Options 3-5, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include a variable indicative of the concentration of at least one target metabolite.
[0185] Option 7. The method of any of Options 3-6, wherein the process variables additionally include one or more variables indicative of one or more intracellular metabolite concentrations in the virtual cell biomass.
[0186] Option 8. The method of any of Options 1-7, wherein the plurality of constraints on the flux rates include an upper limit on at least one of: i) glucose uptake, ii) glutamine uptake, iii) asparagine uptake, or iv) oxygen uptake.
[0187] Option 9. The method of any of Options 1-8, wherein the plurality of constraints on the rates of change include a lower limit on a rate of energy consumption maintained by the cell.
[0188] Option 10. The method of any one of Options 1-9, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of a value of at least one of the following on an upper limit of a metabolite uptake rate:
[0189] i) temperature, ii) acidity, or iii) osmolarity.
[0190] Option 11. The method described in Option 10,
[0191] Wherein modeling the one or more effects of at least some of the current values of the process variables on the metabolic reaction kinetics comprises calculating the effect of an upper limit on the metabolite uptake rate by multiplying the upper limit by a correction factor that indicates a reduction in the uptake rate due to non-ideal conditions.
[0192] Option 12. The method of any of Options 1-11, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of stress on a lower limit on the rate of energy consumption maintained by the cell.
[0193] Option 13. The method of Option 12, wherein modeling the effect of stress comprises calculating the effect based at least in part on a cumulative effect of temperature variation on the virtual cell biomass.
[0194] Option 14. The method of any of Options 1-13, wherein the one or more effects of the at least some of the current values of the process variables on metabolic reaction kinetics include an effect on the concentration of at least one of the metabolic byproducts.
[0195] Option 15. The method of any of Options 1-14, wherein modeling the one or more effects comprises calibrating the modeled effects with experimental data from real-world cell culture.
[0196] Option 16. The method of any of Options 1-15, wherein the metabolic goal comprises minimizing the ratio of linear combinations of at least some of the flux rates and squares of the flux rates in the flux balance analysis.
[0197] Option 17. The method of any of Options 1-15, wherein the metabolic goal comprises minimizing a linear combination of at least some of the flux rates in the flux balance analysis.
[0198] Option 18. The method of Option 17, wherein the linear combination is the sum of the fluxes in the flux balance analysis.
[0199] Option 19. The method of any of Options 1-18, wherein the metabolic goal comprises maximizing the rate of energy expenditure for cellular maintenance.
[0200] Option 20. The method of any one of Options 1-19, wherein the metabolic goal comprises maximizing the growth rate of the virtual cell biomass.
[0201] Option 21. The method of any one of options 1-20, further comprising:
[0202] One or more variables indicative of flow rates and compositions of one or more virtual input streams are received into the modeled bioreactor, and wherein
[0203] Updating the at least some of the current values of the process variables includes accounting for flow rates and compositions of the one or more virtual input streams.
[0204] Option 22. The method of Option 21, further comprising:
[0205] receiving one or more variables indicating properties of a virtual output filter;
[0206] The composition of one or more virtual output streams from the modeled bioreactor is calculated using the properties of the virtual output filter, and wherein
[0207] Updating the at least some of the current values of the process variables includes interpreting the composition of the one or more virtual output streams.
[0208] Option 23. The method of Option 21, wherein updating at least some of the current values of the process variables includes solving mass balance equations.
[0209] Option 24. The method of any one of options 1-23, further comprising:
[0210] receives one or more control variables, and
[0211] An affected set of the current values of the process variables are updated based at least in part on the received control variables.
[0212] Option 25. The method of any one of options 1-24, wherein
[0213] The measure of the modeled bioreactor includes values of at least one of the process variables at different virtual times during the simulation time period.
[0214] Option 26. The method of any one of options 1-25, wherein
[0215] The metric of the computationally modeled bioreactor indicates the effectiveness or efficiency of the computationally modeled bioreactor in producing a target product.
[0216] Option 27. The method of any one of options 1-26, wherein
[0217] The method comprises generating the control setting, and wherein
[0218] The method further includes controlling an input to a real-world bioreactor based on the generated control settings.
[0219] Option 28. A method as described in any of options 1-27, wherein
[0220] The method includes generating a training set for the artificial intelligence model for the bioreactor.
[0221] Option 29. The method of any one of options 1-28, wherein
[0222] The virtual cell biomass includes virtual Chinese hamster ovary (CHO) cells.
[0223] Option 30. The method of any one of Options 1-29, wherein receiving the plurality of current values comprises at least one of the following:
[0224] i) receiving a value from a user via a graphical user interface;
[0225] ii) receiving values based on measurements of real bioreactors;
[0226] iii) loading values from computer memory based on previously calculated values; or
[0227] iv) Loading predetermined default values from computer memory.
[0228] Option 31. The method of any of Options 1-30, wherein the modeled bioreactor is a spatially homogeneous bioreactor and the at least portion of the modeled bioreactor is the entirety of the spatially homogeneous bioreactor.
[0229] Option 32. The method of any one of options 1-30, wherein:
[0230] The bioreactor modeled is a spatially heterogeneous bioreactor;
[0231] The at least portion of the modeled bioreactor is a first portion of the modeled bioreactor;
[0232] These process variables are first process variables;
[0233] The method further includes receiving a plurality of current values of second process variables describing second virtual contents in a second portion of the modeled bioreactor; and
[0234] Calculating new values of the first process variables during the simulation time period is based in part on the received current values of the second process variables.
[0235] Option 33. The method of Option 32, wherein calculating new values of the first process variables during the simulation time period includes calculating a gradient of at least one of the first process variables based on a value of a corresponding variable of the second process variables.
[0236] Option 34. The method of any one of options 32-33, further comprising:
[0237] One or more velocities associated with the virtual contents of the first portion of the modeled bioreactor are determined.
[0238] Option 35. The method of Option 34, wherein:
[0239] Determining the one or more speeds is based at least in part on computational fluid dynamics.
[0240] Option 36. A non-transitory computer readable medium storing instructions for computationally modeling a bioreactor, wherein the instructions, when executed by one or more processors, cause the one or more processors to:
[0241] receiving a plurality of current values of process variables describing virtual contents of a modeled bioreactor, the virtual contents including virtual cellular biomass in a virtual extracellular solution;
[0242] New values of the process variables during the simulation time period are calculated by processing hardware of the computing system at least in part by:
[0243] generating a plurality of constraints on flux rates describing metabolic flux of the virtual cell biomass by modeling one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics,
[0244] The flux rates of the metabolic fluxes are calculated by performing a flux balance analysis that is influenced by the metabolic target and the multiple constraints generated for the flux rates.
[0245] calculating a rate of change of at least some of the process variables based at least in part on the calculated flux rate, and
[0246] updating one or more of the current values of the process variables at least in part by integrating one or more of the calculated rates of change for virtual time steps within the simulation time period;
[0247] calculating, by the processing hardware, metrics of the modeled bioreactor based on the calculated new values of the process variables; and
[0248] One or more of the following is generated by the processing hardware and based on the measurements of the modeled bioreactor: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of the bioreactor.
[0249] Option 37. The non-transitory computer readable medium of Option 36, wherein the process variables include at least one of: temperature, acidity, or one or more variables indicative of a total osmolarity of the virtual contents.
[0250] Option 38. The non-transitory computer readable medium of any of Options 36-37, wherein the process variables include one or more variables indicating the concentration of the virtual cellular biomass and one or more variables indicating the concentration of extracellular metabolites in the virtual extracellular solution.
[0251] Option 39. The non-transitory computer readable medium of Option 38, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include one or more variables indicative of the concentration of at least one of: oxygen, carbon dioxide, or ammonia.
[0252] Option 40. The non-transitory computer readable medium of any of Options 38-39, wherein the one or more variables indicative of the concentration of an extracellular metabolite in the virtual extracellular solution include variables indicative of the concentration of one or more of: glucose, asparagine, glutamine, or glycine.
[0253] Option 41. The non-transitory computer readable medium of any of Options 38-40, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include a variable indicative of the concentration of at least one target metabolite.
[0254] Option 42. The non-transitory computer readable medium of any of Options 38-41, wherein the process variables further include variables indicative of one or more intracellular metabolite concentrations in the virtual cell biomass.
[0255] Option 43. The non-transitory computer readable medium of any of Options 36-42, wherein the plurality of constraints on the rate of change include an upper limit on at least one of: i) glucose uptake, ii) glutamine uptake, iii) asparagine uptake, or iv) oxygen uptake.
[0256] Option 44. The non-transitory computer readable medium of any of Options 36-43, wherein the plurality of constraints on the rate of change include a lower limit on a rate of energy consumption maintained by the cell.
[0257] Option 45. The non-transitory computer readable medium of any of Options 36-44, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of a value of at least one of the following on an upper limit on a metabolite uptake rate:
[0258] i) temperature, ii) acidity, or iii) osmolarity.
[0259] Option 46. The non-transitory computer readable medium of Option 45, wherein
[0260] Modeling the one or more effects of at least some of the current values of the process variables on the metabolic reaction kinetics includes calculating the effect of an upper limit on the metabolite uptake rate by multiplying the upper limit by a correction factor that indicates a reduction in the uptake rate due to non-ideal conditions.
[0261] Option 47. The non-transitory computer readable medium of any of Options 36-46, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of stress on a lower limit on the rate of energy consumption maintained for the cell.
[0262] Option 48. The non-transitory computer readable medium of Option 47, wherein modeling the effect of stress comprises calculating the effect based at least in part on a cumulative effect of temperature variation on the virtual cell biomass.
[0263] Option 49. The non-transitory computer readable medium of any of Options 36-48, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect on the concentration of at least one of the metabolic byproducts.
[0264] Option 50. The non-transitory computer readable medium of any of Options 36-49, wherein modeling the one or more effects comprises calibrating the modeled effects with experimental data from real-world cell culture.
[0265] Option 51. The non-transitory computer readable medium of any of Options 36-50, wherein the metabolic goal comprises minimizing a linear combination of at least some of the rates of change.
[0266] Option 52. The non-transitory computer readable medium of any of Options 36-51, wherein the metabolic goal comprises minimizing a linear combination of at least some fluxes in the flux balance analysis.
[0267] Option 53. The non-transitory computer readable medium of Option 52, wherein the linear combination is the sum of the fluxes in the flux balance analysis.
[0268] Option 54. The non-transitory computer readable medium of any of Options 36-53, wherein the metabolic goal comprises maximizing a rate of energy expenditure for cell maintenance.
[0269] Option 55. The non-transitory computer readable medium of any one of Options 36-54, wherein the metabolic goal comprises maximizing a growth rate of the virtual cell biomass.
[0270] Option 56. The non-transitory computer readable medium of any of Options 36-55, wherein the instructions further cause the one or more processors to:
[0271] One or more variables indicative of flow rates and compositions of one or more virtual input streams are received into the modeled bioreactor, and wherein
[0272] Updating the at least some of the current values of the process variables includes accounting for flow rates and compositions of the one or more virtual input streams.
[0273] Option 57. The non-transitory computer readable medium of Option 56, wherein the instructions further cause the one or more processors to:
[0274] receiving one or more variables indicating properties of a virtual output filter;
[0275] The composition of one or more virtual output streams from the modeled bioreactor is calculated using the properties of the virtual output filter, and wherein
[0276] Updating the at least some of the current values of the process variables includes interpreting the composition of the one or more virtual output streams.
[0277] Option 58. The non-transitory computer readable medium of options 56-57, wherein updating the at least some of the current values of the process variables comprises solving a mass balance equation.
[0278] Option 59. The non-transitory computer readable medium of any of Options 36-58, wherein the instructions further cause the one or more processors to:
[0279] receives one or more control variables, and
[0280] An affected set of the current values of the process variables are updated based at least in part on the received control variables.
[0281] Option 60. The non-transitory computer readable medium of any one of Options 36-59, wherein
[0282] The measure of the modeled bioreactor includes values of at least one of the process variables at different virtual times during the simulation time period.
[0283] Option 61. The non-transitory computer readable medium of any one of Option 36-60, wherein
[0284] This metric for the modeled bioreactor indicates the effectiveness or efficiency of the modeled bioreactor in producing the target product.
[0285] Option 62. The non-transitory computer readable medium of any one of Option 36-61, wherein the instructions
[0286] causing the one or more processors to generate the control setting, and
[0287] The one or more processors are further caused to control inputs to the real-world bioreactor based on the generated control settings.
[0288] Option 63. The non-transitory computer readable medium of any one of Option 36-62, wherein the instructions
[0289] The one or more processors are caused to generate a training set for the artificial intelligence model for the bioreactor.
[0290] Option 64. A non-transitory computer readable medium as described in any of Option 36-63, wherein
[0291] The virtual cell biomass includes virtual Chinese hamster ovary (CHO) cells.
[0292] Option 65. The non-transitory computer readable medium of any one of Options 36-64, wherein receiving the plurality of current values comprises at least one of:
[0293] i) receiving a value from a user via a graphical user interface;
[0294] ii) receiving values based on measurements of real bioreactors;
[0295] iii) loading values from computer memory based on previously calculated values; or
[0296] iv) Loading predetermined default values from computer memory.
[0297] Option 66. The non-transitory computer readable medium of any of Options 36-65, wherein the modeled bioreactor is a spatially homogeneous bioreactor, and the at least portion of the modeled bioreactor is the entirety of the spatially homogeneous bioreactor.
[0298] Option 67. The non-transitory computer readable medium of any one of Option 36-65, wherein:
[0299] The bioreactor modeled is a spatially heterogeneous bioreactor;
[0300] The at least portion of the modeled bioreactor is a first portion of the modeled bioreactor;
[0301] These process variables are first process variables;
[0302] The instructions further cause the one or more processors to receive a plurality of current values of second process variables describing second virtual contents in a second portion of the modeled bioreactor; and
[0303] Calculating new values of the first process variables during the simulation time period is based in part on the received current values of the second process variables.
[0304] Option 68. The non-transitory computer readable medium of Option 67, wherein calculating new values of the first process variables during the simulation time period comprises calculating a gradient of at least one of the first process variables based on a value of a corresponding variable of the second process variables.
[0305] Option 69. The non-transitory computer readable medium of any of Options 67-68, wherein the instructions further cause the one or more processors to determine one or more velocities associated with the virtual contents of the first portion of the modeled bioreactor.
[0306] Option 70. The non-transitory computer readable medium of any one of Option 67-69, wherein:
[0307] Determining the one or more speeds is based at least in part on computational fluid dynamics.
[0308] Those skilled in the art will appreciate that various modifications, changes and combinations may be made to the embodiments described above without departing from the scope of the present invention, and such modifications, changes and combinations may be considered to be within the scope of the present inventive concept.
Claims
1. A method of computationally modeling a bioreactor, the method accounting for spatial heterogeneity between multiple parts of the modeled bioreactor, wherein the method comprises: receiving a plurality of current values of process variables describing a first virtual content of a first portion of a modeled bioreactor and, for each portion, describing one or more additional virtual contents of corresponding one or more additional portions of the modeled bioreactor, and the virtual contents including virtual cellular biomass in a virtual extracellular solution; New values of the process variables during the simulation time period are calculated by processing hardware of the computing system at least in part by: generating a plurality of constraints on flux rates describing metabolic flux of the virtual cell biomass by modeling one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics, The flux rates of the metabolic fluxes are calculated by performing a flux balance analysis that is influenced by the metabolic target and the multiple constraints generated for the flux rates. calculating a rate of change of at least some of the process variables based at least in part on the calculated flux rate, and updating one or more of the current values of the process variables at least in part by integrating one or more of the calculated rates of change for virtual time steps within the simulation time period; calculating, by the processing hardware, a metric of the computationally modeled bioreactor based at least in part on the calculated new values of the process variables; and One or more of the following is generated by the processing hardware and based on the measurements of the modeled bioreactor: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of the bioreactor.
2. The method of claim 1, wherein the process variables include at least one of: temperature, acidity, or one or more variables indicative of total osmolarity of the virtual contents.
3. The method of claim 1, wherein the process variables include one or more variables indicative of the concentration of the virtual cellular biomass and one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution.
4. The method of claim 3, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include one or more variables indicative of the concentration of at least one of: oxygen, carbon dioxide, or ammonia.
5. The method of claim 3, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include variables indicative of the concentration of one or more of: glucose, asparagine, glutamine, or glycine.
6. The method of claim 3, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include a variable indicative of the concentration of at least one target metabolite.
7. The method of claim 3, wherein the process variables additionally include one or more variables indicative of one or more intracellular metabolite concentrations in the virtual cell biomass.
8. The method of claim 1, wherein the plurality of constraints on the flux rates comprise an upper limit on at least one of: i) glucose uptake, ii) glutamine uptake, iii) asparagine uptake, or iv) oxygen uptake.
9. The method of claim 1, wherein the plurality of constraints on the flux rates include a lower limit on an energy consumption rate maintained by the cells.
10. The method of claim 1, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of a value of at least one of the following on an upper limit of a metabolite uptake rate: i) temperature, ii) acidity, or iii) osmolarity.
11. The method according to claim 10, Wherein modeling the one or more effects of at least some of the current values of the process variables on the metabolic reaction kinetics comprises calculating the effect of an upper limit on the metabolite uptake rate by multiplying the upper limit by a correction factor that indicates a reduction in the uptake rate due to non-ideal conditions.
12. The method of claim 1, wherein the one or more effects of the at least some of the current values of the process variables on metabolic reaction kinetics include an effect of stress on a lower limit on an energy consumption rate maintained by a cell.
13. The method of claim 12, wherein modeling the effect of stress comprises calculating the effect based at least in part on a cumulative effect of temperature variation on the virtual cell biomass.
14. The method of claim 1, wherein the one or more effects of the at least some of the current values of the process variables on metabolic reaction kinetics include an effect on the concentration of at least one of the metabolic byproducts.
15. The method of claim 1, wherein modeling the one or more effects comprises calibrating the modeled effects with experimental data from real-world cell cultures.
16. The method of claim 1, wherein the metabolic goal comprises minimizing the ratio of a linear combination of at least some of the flux rates and the squares of the flux rates in the flux balance analysis.
17. The method of claim 1, wherein the metabolic goal comprises minimizing a linear combination of at least some of the flux rates in the flux balance analysis.
18. The method of claim 17, wherein the linear combination is the sum of the fluxes in the flux balance analysis.
19. The method of claim 1, wherein the metabolic goal comprises maximizing the rate of energy expenditure for cellular maintenance.
20. The method of claim 1, wherein the metabolic goal comprises maximizing the growth rate of the virtual cell biomass.
21. The method of claim 1, further comprising: receiving one or more variables indicative of flow rates and compositions of one or more virtual input streams into at least one of the first portion or the one or more further portions of the modeled bioreactor, and wherein Updating the at least some of the current values of the process variables includes accounting for flow rates and compositions of the one or more virtual input streams.
22. The method of claim 21, further comprising: receiving one or more variables indicative of properties of a virtual output filter; calculating the composition of one or more virtual output streams from the modeled bioreactor using the properties of the virtual output filter, and wherein Updating the at least some of the current values of the process variables comprises accounting for the composition of the one or more virtual output streams from at least one of the first portion or the one or more further portions of the modeled bioreactor.
23. The method of claim 21, wherein updating at least some of the current values of the process variables includes solving a mass balance equation.
24. The method of claim 1, further comprising: receives one or more control variables, and An affected set of the current values of the process variables are updated based at least in part on the received control variables.
25. The method of claim 1, wherein The measure of the modeled bioreactor includes values of at least one of the process variables at different virtual times during the simulation time period.
26. The method of claim 1, wherein The metric of the computationally modeled bioreactor indicates the effectiveness or efficiency of the computationally modeled bioreactor in producing a target product.
27. The method of claim 1, wherein The method comprises generating the control setting, and wherein The method further includes controlling an input to a real-world bioreactor based on the generated control settings.
28. The method of claim 1, wherein The method includes generating a training set for the artificial intelligence model for the bioreactor.
29. The method of claim 1, wherein The virtual cell biomass includes virtual Chinese hamster ovary (CHO) cells.
30. The method of claim 1, wherein receiving the plurality of current values comprises at least one of: i) receiving a value from a user via a graphical user interface; ii) receiving values based on measurements of real bioreactors; iii) loading values from computer memory based on previously calculated values; or iv) Loading predetermined default values from computer memory.
31. The method of claim 1, wherein: The process variables include a first process variable and one or more further process variables, the first process variable describing the first virtual content and the one or more further process variables describing respective virtual contents of one or more further virtual contents; The method further includes receiving a plurality of current values of the one or more additional process variables; as well as Calculating new values of the first process variables during the simulation time period is based in part on the received current values of the one or more additional process variables.
32. The method of claim 31 , wherein calculating new values of the first process variables during the simulation time period comprises calculating a gradient of at least one of the first process variables based on a value of a corresponding variable of the one or more additional process variables.
33. The method of claim 31, further comprising: One or more speeds associated with the first virtual content are determined.
34. The method of claim 33, wherein Determining the one or more speeds is based at least in part on computational fluid dynamics.
35. A non-transitory computer readable medium storing instructions for computationally modeling a bioreactor and accounting for spatial heterogeneity between portions of the modeled bioreactor, wherein the instructions, when executed by one or more processors, cause the one or more processors to: receiving a plurality of current values of process variables describing a first virtual content in a first portion of a modeled bioreactor and, for each portion, describing one or more additional virtual contents of corresponding one or more additional portions of the modeled bioreactor, and the virtual contents including virtual cellular biomass in a virtual extracellular solution; New values of the process variables during the simulation time period are calculated by processing hardware of the computing system at least in part by: generating a plurality of constraints on flux rates describing metabolic flux of the virtual cell biomass by modeling one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics, The flux rates of the metabolic fluxes are calculated by performing a flux balance analysis that is influenced by the metabolic target and the multiple constraints generated for the flux rates. calculating a rate of change of at least some of the process variables based at least in part on the calculated flux rate, and updating one or more of the current values of the process variables at least in part by integrating one or more of the calculated rates of change for virtual time steps within the simulation time period; calculating, by the processing hardware, metrics of the modeled bioreactor based at least in part on the calculated new values of the process variables; and One or more of the following is generated by the processing hardware and based on the measurements of the modeled bioreactor: i) information displayed to a user via a user interface, ii) control settings for a real-world bioreactor, or iii) a training set for an artificial intelligence model of the bioreactor.
36. The non-transitory computer readable medium of claim 35, wherein the process variables include at least one of: temperature, acidity, or one or more variables indicative of total osmolarity of the virtual contents.
37. The non-transitory computer readable medium of claim 35, wherein the process variables include one or more variables indicative of the concentration of the virtual cellular biomass and one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution.
38. The non-transitory computer readable medium of claim 37, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include one or more variables indicative of the concentration of at least one of: oxygen, carbon dioxide, or ammonia.
39. The non-transitory computer readable medium of claim 37, wherein the one or more variables indicative of the concentration of an extracellular metabolite in the virtual extracellular solution include variables indicative of the concentration of one or more of: glucose, asparagine, glutamine, or glycine.
40. The non-transitory computer readable medium of claim 37, wherein the one or more variables indicative of the concentration of extracellular metabolites in the virtual extracellular solution include a variable indicative of the concentration of at least one target metabolite.
41. The non-transitory computer readable medium of claim 37, wherein the process variables additionally include variables indicative of one or more intracellular metabolite concentrations in the virtual cellular biomass.
42. The non-transitory computer readable medium of claim 35, wherein the plurality of constraints on the flux rate comprises an upper limit on at least one of: i) glucose uptake, ii) glutamine uptake, iii) asparagine uptake, or iv) oxygen uptake.
43. The non-transitory computer readable medium of claim 35, wherein the plurality of constraints on flux rate include a lower limit on an energy consumption rate maintained by the cells.
44. The non-transitory computer readable medium of claim 35, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of a value of at least one of the following on an upper limit on a metabolite uptake rate: i) temperature, ii) acidity, or iii) osmolarity.
45. The non-transitory computer readable medium of claim 44, wherein Modeling the one or more effects of at least some of the current values of the process variables on the metabolic reaction kinetics includes calculating the effect of an upper limit on the metabolite uptake rate by multiplying the upper limit by a correction factor that indicates a reduction in the uptake rate due to non-ideal conditions.
46. The non-transitory computer readable medium of claim 35, wherein the one or more effects of at least some of the current values of the process variables on metabolic reaction kinetics include an effect of stress on a lower limit on an energy consumption rate maintained by a cell.
47. The non-transitory computer readable medium of claim 46, wherein modeling the effect of stress comprises calculating the effect based at least in part on a cumulative effect of temperature variation on the virtual cell biomass.
48. The non-transitory computer readable medium of claim 35, wherein the one or more effects of the at least some of the current values of the process variables on metabolic reaction kinetics include an effect on the concentration of at least one of the metabolic byproducts.
49. The non-transitory computer readable medium of claim 35, wherein modeling the one or more effects comprises calibrating the modeled effects with experimental data from real-world cell cultures.
50. The non-transitory computer readable medium of claim 35, wherein the metabolic goal comprises minimizing a linear combination of at least some of the rates of change.
51. The non-transitory computer readable medium of claim 35, wherein the metabolic goal comprises minimizing a linear combination of at least some flux rates in the flux balance analysis.
52. The non-transitory computer readable medium of claim 51, wherein the linear combination is the sum of the fluxes in the flux balance analysis.
53. The non-transitory computer readable medium of claim 35, wherein the metabolic goal comprises maximizing a rate of energy expenditure for cellular maintenance.
54. The non-transitory computer readable medium of claim 35, wherein the metabolic goal comprises maximizing a growth rate of the virtual cell biomass.
55. The non-transitory computer readable medium of claim 35, wherein the instructions further cause the one or more processors to: receiving one or more variables indicative of flow rates and compositions of one or more virtual input streams into at least one of the first portion or the one or more further portions of the modeled bioreactor, and wherein Updating the at least some of the current values of the process variables includes accounting for flow rates and compositions of the one or more virtual input streams.
56. The non-transitory computer readable medium of claim 55, wherein the instructions further cause the one or more processors to: receiving one or more variables indicating properties of a virtual output filter; The composition of one or more virtual output streams from at least one of the first part or the one or more further parts of the modelled bioreactor is calculated using the properties of the virtual output filter, and wherein Updating the at least some of the current values of the process variables includes interpreting the composition of the one or more virtual output streams.
57. The non-transitory computer readable medium of claim 55, wherein updating the at least some of the current values of the process variables comprises solving a mass balance equation.
58. The non-transitory computer readable medium of claim 35, wherein the instructions further cause the one or more processors to: receives one or more control variables, and An affected set of the current values of the process variables are updated based at least in part on the received control variables.
59. The non-transitory computer readable medium of claim 35, wherein The measure of the modeled bioreactor includes values of at least one of the process variables at different virtual times during the simulation time period.
60. The non-transitory computer readable medium of claim 35, wherein This metric for the modeled bioreactor indicates the effectiveness or efficiency of the modeled bioreactor in producing the target product.
61. The non-transitory computer readable medium of claim 35, wherein the instructions causing the one or more processors to generate the control setting, and The one or more processors are further caused to control inputs to the real-world bioreactor based on the generated control settings.
62. The non-transitory computer readable medium of claim 35, wherein the instructions The one or more processors are caused to generate a training set for the artificial intelligence model for the bioreactor.
63. The non-transitory computer readable medium of claim 35, wherein The virtual cell biomass includes virtual Chinese hamster ovary (CHO) cells.
64. The non-transitory computer readable medium of claim 35, wherein receiving the plurality of current values comprises at least one of: i) receiving a value from a user via a graphical user interface; ii) receiving values based on measurements of real bioreactors; iii) loading values from computer memory based on previously calculated values; or iv) Loading predetermined default values from computer memory.
65. The non-transitory computer readable medium of claim 35, wherein The process variables include a first process variable and one or more further process variables, the first process variable describing the first virtual content and the one or more further process variables describing respective virtual contents of one or more further virtual contents; The instructions further cause the one or more processors to: receiving a plurality of current values of the one or more additional process variables; and Calculating new values of the first process variables during the simulation time period is based in part on the received current values of the one or more additional process variables.
66. The non-transitory computer readable medium of claim 65, wherein calculating new values of the first process variables during the simulation time period comprises calculating a gradient of at least one of the first process variables based on a value of a corresponding variable in the one or more additional process variables.
67. The non-transitory computer readable medium of claim 65, wherein the instructions further cause the one or more processors to determine one or more speeds associated with the first virtual content.
68. The non-transitory computer readable medium of claim 67, wherein Determining the one or more speeds is based at least in part on computational fluid dynamics.
